Sources: 1BitterDB, 4ClinicalTrials, 7Cochrane Library, 10DGIdb, 14DrugBank, 29HMDB, 33IUPHAR, 46NDF-RT, 50Novoseek, 56PharmGKB, 68UMLSSee all MalaCards sources |
Drugs for Plasma Cell Neoplasm (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB): (show top 50)
(show all 1001)
| id | | Name | Status | Phase | Clinical Trials | Cas Number | PubChem Id |
|---|
| 1 | | Doxorubicin | approved, investigational | Phase 4, Phase 3, Phase 2, Phase 1 | 1751 | 23214-92-8 | 31703 | (1S,3S)-3-Glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside (8S-cis)-10-((3-amino-2,3,6-Trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione 111266-55-8 14-Hydroxydaunomycin 14-Hydroxydaunorubicine 14-hydroxydaunomycin 14-hydroxydaunorubicine 23214-92-8 23257-17-2 24385-08-8 25311-50-6 25316-40-9 25316-40-9 (hydrochloride) 29042-30-6 AC1L1M5T AC1Q29OJ ADM ADR Adriablastin Adriacin (hydrochloride salt) Adriamycin Adriamycin PFS Adriamycin PFS (hydrochloride salt) Adriamycin RDF Adriamycin RDF (hydrochloride salt) Adriamycin Semiquinone Adriamycin semiquinone Adriblas tina Adriblastin Adriblastina Adriblastina (TN) Adriblastina (hydrochloride salt) Aerosolized Doxorubicin BPBio1_000502 BRD-K92093830-003-04-3 BSPBio_000456 BSPBio_001031 C01661 C27H29NO11 CCRIS 739 CHEBI:28748 CHEMBL179 CID31703 Caelyx Conjugate of doxorubicin with humanized monoclonal antibody LL1 against CD74 Conjugate of doxorubicin with monoclonal antibody P4/D10 against GP120 D03899 DB00997 DM2 DOX-SL Doxil Doxo Doxorubicin Doxorubicin (USAN/INN) Doxorubicin HCl | Doxorubicin Hydrochloride Doxorubicin [USAN:INN:BAN] Doxorubicin citrate Doxorubicin hydrochloride (hydrochloride salt) Doxorubicin-P4/D10 Doxorubicin-P4/D10 conjugate Doxorubicin-hLL1 Doxorubicin-hLL1 conjugate Doxorubicina Doxorubicina [INN-Spanish] Doxorubicine Doxorubicine [INN-French] Doxorubicinum Doxorubicinum [INN-Latin] EINECS 245-495-6 FI 106 Farmablastina (hydrochloride salt) HMS2089H06 HSDB 3070 Hydroxydaunomycin hydrochlor ide (hydrochloride salt) Hydroxydaunomycin hydrochloride (hydrochloride salt) Hydroxydaunorubicin Hydroxydaunorubicin hydrochloride (hydrochloride salt) JT9100000 LMPK13050001 LS-1029 LS-165655 MLS000759533 Myocet NCI-C01514 NChemBio.2007.10-comp13 NDC 38242-874 NIOSH/JT9100000 NSC 123127 Prestwick0_000438 Prestwick1_000438 Prestwick2_000438 Prestwick3_000438 Probes1_000151 Probes2_000129 RDF Rubex Resmycin Rubex Rubex (hydrochloride salt) SMP1_000106 SPBio_002395 TLC D-99 ThermoDox Triferric doxorubicin UNII-80168379AG adiblastine (hydrochloride salt) adr iablatina (hydrochloride salt) adriablastine (hydrochloride salt) adriablatina (hydrochloride salt) adriblatina (hydrochloride salt) doxorubicin nchembio809-comp5 |
| | 2 | | Simvastatin | approved | Phase 4, Phase 3, Phase 2, Phase 1, Early Phase 1 | 519 | 79902-63-9 | 54454 | (+)-Simvastatin (1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate 2,2-Dimethylbutanoic acid (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester 2,2-Dimethylbutyric acid, 8-ester with (4R,6R)-6-(2-((1S,2S,6R,8S,8aR)-1,2,6,7,8,8a-hexahydro-8-hydroxy-2,6-dimethyl-1-naphthyl)ethyl)tetrahydro-4-hydroxy-2H-pyran-2-one 2,2-Dimethylbutyric acid, 8-ester with (4R,6R)-6-(2-((1S,2S,6R,8S,8ar)-1,2,6,7,8,8a-hexahydro-8-hydroxy-2,6-dimethyl-1-naphthyl)ethyl)tetrahydro-4-hydroxy-2H-pyran-2-one 79902-63-9 AC-1530 AC1L1H1F AKOS005111006 ARONIS24119 BCBcMAP01_000007 BIDD:GT0769 BPBio1_001001 BRD-K22134346-001-05-8 BRN 4768037 BSPBio_000909 BSPBio_002337 Bio-0672 Butanoic acid, 2,2-dimethyl-, (1S,3R,7S,8S,*aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-((2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester Butanoic acid, 2,2-dimethyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-((2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester Butanoic acid, 2,2-dimethyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester C25H38O5 CCRIS 7558 CHEBI:9150 CHEMBL1064 CID54454 CPD000718785 Cholestat Coledis Colemin Corolin D00434 D019821 DRG-0320 Denan DivK1c_006991 Eucor HMS1570N11 HMS1922H13 HMS2089D12 HMS2093E06 HSDB 7208 InChI=1/C25H38O5/c1-6-25(4,5)24(28)30-21-12-15(2)11-17-8-7-16(3)20(23(17)21)10-9-19-13-18(26)14-22(27)29-19/h7-8,11,15-16,18-21,23,26H,6,9-10,12-14H2,1-5H3/t15-,16-,18+,19+,20-,21-,23-/m0/s1 KBio1_001935 KBio2_002197 KBio2_004765 KBio2_007333 KBio3_001557 KBioGR_001244 KBioSS_002197 KS-1113 Kolestevan L 644128-000U LS-46264 Labistatin Lipex Lipinorm Liponorm Lipovas Lodales MK 0733 MK 733 MK-0733 MK-733 MK733 MLS001304029 MLS001333077 MLS001333078 | MLS002154038 Medipo Modutrol MolPort-002-507-345 MolPort-002-885-862 NCGC00017324-01 NCGC00017324-02 NCGC00017324-03 Nivelipol Nor-Vastina Pantok Pepstatin Prestwick0_000865 Prestwick1_000865 Prestwick2_000865 Prestwick3_000865 Prestwick_171 Rechol Rendapid S1792_Selleck S6196_SIGMA SAM002589969 SMR000718785 SPBio_001881 SPBio_002830 SPECTRUM1504236 STK801938 Simcor Simovil Simvast CR Simvastatin Simvastatin & Primycin Simvastatin (JAN/USP/INN) Simvastatin [USAN:INN:BAN] Simvastatin [Usan:Ban:Inn] Simvastatin lactone Simvastatin, Compactin Simvastatina Simvastatina [Spanish] Simvastatine Simvastatine [French] Simvastatinum Simvastatinum [Latin] Simvotin Sinvacor Sinvascor Sivastin SpecPlus_000895 Spectrum2_001671 Spectrum3_000669 Spectrum4_000632 Spectrum5_001428 Spectrum_001717 Statin Synvinolin TNP00259 UNII-AGG2FN16EV Valemia Vasotenal Velostatin Vytorin ZINC03780893 Zocor Zocor (TN) Zocor, Simlup, Simcard, Simvacor, Simvoget, Zorced, Simvastatin Zocord [(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] 2,2-dimethylbutanoate butanoic acid, 2,2-dimethyl-,1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)-ethyl]-1-naphthalenyl ester, [1S-[1 alpha,3 alpha,7 beta,8 beta(2S*,4S*),-8a beta nchembio790-comp16 simvastatin |
| | 3 | | Methotrexate | approved | Phase 4, Phase 3, Phase 2, Phase 1 | 1551 | 1959-05-2, 59-05-2 | 126941 | 4-amino-10-methylfolic acid 4-amino-N(10)-methylpteroylglutamic acid Abitrexate Amethopterin Amethopterine Antifolan Arbitrexate Emtexate Folex HDMTX L-Amethopterin Ledertrexate MTX Metatrexan | Methopterin Methotextrate Methotrate Methotrexat Methotrexate Sodium Methotrexatum Methylaminopterin Methylaminopterinum Metotrexato Mexate Méthotrexate N-Bismethylpteroylglutamic Acid N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamic acid Rheumatrex Trexall | |
| | 4 | | Hydrocortisone | approved, vet_approved | Phase 4, Phase 2, Phase 1 | 667 | 50-23-7 | 5754, 657311 | (11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione (11beta)-11,17,21-Trihydroxypregn-4-ene-3,20-dione 11-Hydrocortisone 11-beta-Hydrocortisone 11-beta-Hydroxycortisone 11a-Hydroxycorticosterone 11alpha-Hydroxycorticosterone 11b,17,21-Trihydroxyprogesterone 11b-Hydrocortisone 11b-Hydroxycortisone 11beta,17,21-Trihydroxyprogesterone 11beta,17alpha,21-Trihydroxy-4-pregnene-3,20-dione 11beta-Hydrocortisone 11beta-Hydroxycortisone 11beta-hydrocortisone 11β-hydrocortisone 17-Hydroxycorticosterone 17a-Hydroxycorticosterone 17alpha-Hydroxycorticosterone 2v95 4-Pregnen-11beta,17alpha,21-triol-3,20-dione 4-Pregnene-11alpha,21-triol 3,20-dione 4-Pregnene-11b,17a,21-triol-3,20-dione 50-23-7 8056-08-4 80562-38-5 8063-42-1 AC-12902 AC1L1L2B ACETASOL HC ACETIC ACID W/ HYDROCORTISONE AI3-25006 AKOS001582651 Acticort Acticort (TN) Aeroseb HC Aeroseb-HC Ala-Cort Ala-Scalp Alacort Algicirtis Alphaderm Amberin Anflam Anti-inflammatory hormone Anucort Anucort-HC Anusol HC Anusol HC (TN) Aquacort Aquanil HC B48448A1-24BA-47CA-8D9E-43E5BC949386 BPBio1_000544 BRD-K93568044-001-03-1 BSPBio_000494 Balneol-hc Barseb HC Basan-Corti Beta-hc Bio-0648 C00735 C21H30O5 CCRIS 5854 CHEBI:17650 CHEMBL389621 CID5754 COR-OTICIN CPD000653523 CaldeCORT Spray Cetacort Chronocort Clear aid Cleiton Cobadex Colocort Colocort (TN) Compound F Compound F (kendall) Cor-Tar-Quin Corhydron Cort-Dome Cort-Quin Cortanal Cortef Cortef (TN) Cortenema Cortesal Corticreme Cortifair Cortifan Cortifoam Cortiment Cortisol Cortisol alcohol Cortisol, Hydrocortisone Cortisolonum Cortisporin Cortisporin Otico Cortispray Cortizol Cortolotion Cortonema Cortoxide Cortril Cremesone Cremicort-H Cutisol Cyclodextrin-encapsulated hydrocortisone D00088 DB00741 DB07886 Delacort Derm-Aid Dermacort Dermaspray Dermil Dermocortal Dermolate Dihydrocostisone Dioderm Dome-cort Domolene-HC Drotic DuoCort EINECS 200-020-1 EU-0100594 Ef corlin Efcorbin Efcortelan Efcortelin Eldecort Eldercort Epicort Epicortisol Epiderm H Esiderm H Evacort Ficortril Fiocortril Flexicort Foille Insetti Genacort Genacort (lotion) Glycort Gyno-Cortisone H 4001 H-Cort H0135_SIGMA H0396_SIGMA H0888_SIGMA H3160_SIGMA H4001_SIGMA H6909_SIGMA HC HC #1 | HC #4 HC (HYDROCORTISONE) HMS1569I16 HMS2090M04 HSDB 3339 HYDROCORTISONE AND ACETIC ACID HYDROCORTISONE IN ABSORBASE Heb Cort Heb-Cort Hi-cor Hidalone Hidro-Colisona Hidrocortisona Hidrocortisona [INN-Spanish] Hycort Hycortol Hycortole Hydracort Hydrasson Hydro-Adreson Hydro-Colisona Hydro-RX Hydro-colisona Hydrocort Hydrocortal Hydrocorticosterone Hydrocortisone Hydrocortisone (JP15/USP/INN) Hydrocortisone Acetate Hydrocortisone Base Hydrocortisone Butyrate Hydrocortisone Sodium Phosphate Hydrocortisone Valerate Hydrocortisone [INN:BAN:JAN] Hydrocortisone alcohol Hydrocortisone base Hydrocortisone free alcohol Hydrocortisone solution Hydrocortisone-Water Soluble Hydrocortisonum Hydrocortisonum [INN-Latin] Hydrocortistab Hydrocortisyl Hydrocortone Hydroskin Hydroxycortisone Hysone Hytisone Hytone Hytone (TN) Hytone lotion Idrocortisone Idrocortisone [DCIT] Incortin-H Incortin-hydrogen Kendall'S compound F Kendall's compound F Komed HC Kyypakkaus LMST02030001 LS-7439 Lacticare HC Lacticare-HC Lactisona Lopac0_000594 Lubricort MLS000069609 MLS001148103 MLS002207135 MLS002222189 Maintasone Medicort Meusicort Mildison Milliderm MolPort-001-794-637 NCGC00022848-06 NCGC00022848-07 NCGC00022848-09 NCGC00022848-12 NCI60_000118 NSC 10483 NSC-10483 NSC10483 Neo-Cort-Dome Neo-Cortef Neosporin-H Ear Nogenic HC Nutracort Nystaform-HC ORLEX HC Optef Otalgine Otic-Neo-Cort-Dome Otobiotic Otocort Otosone-F Pediotic Suspension Penecort Permicort Polcort H Preparation H Hydrocortisone Cream Prepcort Prestwick0_000447 Prestwick1_000447 Prestwick2_000447 Prestwick3_000447 Prestwick_265 Prevex HC Proctocort Proctofoam Proctozone HC Protocort Racet Rectasol-HC Rectoid Reichstein'S substance M Reichstein's substance M Remederm HC S1696_Selleck SAM002264617 SMP1_000156 SMR000059022 SMR000653523 SPBio_002433 Sanatison Scalp-Cort Scalpicin Capilar Schericur Scheroson F Sigmacort Signef Stie-cort Stiefcorcil Synacort Systral Hydrocort Tarcortin Texacort Texacort lotion 25 Timocort Topicort Transderma H Traumaide UNII-WI4X0X7BPJ UPCMLD-DP133 UPCMLD-DP133:001 Uniderm Vioform-Hydrocortisone VoSol HC Vytone Zenoxone [3H]cortisol component of Lubricort component of Neo-Cort-Dome component of Otalgine hydrocortisone | |
| | 5 | | Prednisone | approved, vet_approved | Phase 4, Phase 3, Phase 2, Phase 1, Early Phase 1 | 1398 | 53-03-2 | 5865 | (1S,2R,10S,11S,14R,15S)-14-hydroxy-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-diene-5,17-dione (8S,9S,10R,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione (8xi,9xi,14xi)-17,21-dihydroxypregna-1,4-diene-3,11,20-trione .delta. E .delta.(sup1)-Cortisone .delta.-Cortelan .delta.-Cortisone .delta.-Cortone .delta.-E .delta.1-Cortisone .delta.1-Dehydrocortisone .delta.sone 1,2-Dehydrocortisone 1,4-Pregnadiene-17-alpha,21-diol-3,11,20-trione 1,4-Pregnadiene-17.alpha.,21-diol-3,11,20-trione 1,4-Pregnadiene-17alpha,21-diol-3,11,20-trione 1-Cortisone 1-Dehydrocortisone 17,21-Dihydroxypregna-1,4-diene-3,11,20-trione 17alpha,21-Dihydroxy-1,4-pregnadiene-3,11,20-trione 53-03-2 68-59-7 81552_FLUKA AC-11112 AC1L1LB2 AC1Q29EZ ACon0_000082 ACon1_000297 AI3-52939 Adasone Ancortone Apo-Prednisone Apo-prednisone BPBio1_000323 BRD-K85883481-001-04-2 BSPBio_000293 Betapar Bicortone Bio-0649 C07370 C21H26O5 CCRIS 2646 CHEBI:8382 CHEMBL635 CID5865 CPD001227202 Cartancyl Colisone Cortan Cortancyl Cortidelt Cotone DB00635 Dacorten Dacortin Decortancyl Decortin Decortisyl Dehydrocortisone Dekortin Delcortin Dellacort Dellacort A Delta Cortelan Delta E Delta E. Delta-Cortelan Delta-Dome Delta-cortelan Delta-cortisone Delta-cortone Delta-dome Deltacortene Deltacortisone Deltacortone Deltasone Deltasone, Liquid Pred, Orasone, Adasone, Deltacortisone,Prednisone Deltison Deltisona Deltisone Deltra Di-Adreson Diadreson EINECS 200-160-3 Econosone Encorton Encortone Enkortolon Enkorton Fernisone Fiasone HMS1568O15 HMS2090J13 HSDB 3168 Hostacortin In-Sone Incocortyl | Juvason Kortancyl LMST02030180 LS-1325 Liquid Pred Lisacort Lodotra MEGxm0_000443 MLS001061265 MLS001304073 MLS001335907 MLS001335908 MLS002154191 MLS002207083 Me-Korti Metacortandracin Meticorten Meticorten (Veterinary) Metrevet (Veterinary) MolPort-001-740-041 NCGC00090766-01 NCGC00090766-02 NCGC00090766-03 NCI-C04897 NCI60_000008 NSC 10023 NSC10023 Nisona Nizon Novoprednisone Nurison Orasone Origen Prednisone P1276 P6254_SIGMA PRD Panafcort Panasol Paracort Parmenison Pehacort Precort Predeltin Prednicen-M Prednicorm Prednicort Prednicot Prednidib Prednilonga Prednison Prednisona Prednisona [INN-Spanish] Prednisone Prednisone Intensol Prednisone [INN:BAN] Prednisonum Prednisonum [INN-Latin] Prednitone Prednizon Prednovister Presone Prestwick0_000077 Prestwick1_000077 Prestwick2_000077 Prestwick3_000077 Prestwick_405 Pronison Pronisone Rectodelt Retrocortine S1622_Selleck SAM002264641 SK-Prednisone SMR000718760 SMR001227202 SPBio_002214 Servisone Sone Sterapred Supercortil U 6020 UNII-VB0R961HZT Ultracorten Ultracortene WLN: L E5 B666 CV OV AHTTT&J A1 E1 FV1Q FQ Winpred Wojtab ZINC03875357 Zenadrid Zenadrid (veterinary) Zenadrid [veterinary] delta cortelan delta(sup 1)-Cortisone delta(sup 1)-Dehydrocortisone delta-1-Cortisone delta-1-Dehydrocortisone delta-Cortisone delta-Cortone | |
| | 6 | | Mycophenolate mofetil | approved, investigational | Phase 4, Phase 3, Phase 2, Phase 1, Early Phase 1 | 952 | 128794-94-5 | 5281078 | 115007-34-6 128794-94-5 140401-05-4 2-Morpholinoethyl (4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate 2-Morpholinoethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate 2-Morpholinoethyl (e)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate 2-morpholin-4-ylethyl (4E)-6-[4-hydroxy-7-methyl-6-(methyloxy)-3-oxo-1,3-dihydro-2-benzofuran-5-yl]-4-methylhex-4-enoate 2-morpholin-4-ylethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-2-benzofuran-5-yl)-4-methylhex-4-enoate 4-Hexenoic acid, 6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl -3-oxo-5-isobenzofuranyl)-4-methyl-, 2-(4-morpholinyl)ethyl ester, (4E) AC-1562 AC1NQXZW AC1Q6O6X AR-1J6939 BB_NC-2566 C07908 C23H31NO7 CHEMBL1456 CID5281078 CellCept CellCept, RS 61443, TM-MMF, Mycophenolate mofetil Cellcept Cellcept (TN) D00752 DB00688 HMS2090A03 | HSDB 7436 I01-0898 I06-1947 LS-172272 LS-75572 ME-MPA MMF MMF CellCept(TM) MolPort-000-883-800 Munoloc Mycophenolate mofetil (JAN/USAN) Mycophenolic acid morpholinoethyl ester Mycophenylate mofetil NCGC00159459-02 NCGC00159459-03 NSC724229 R-99 RS 61443 RS-61443 RS-61443-190 S1501_Selleck TL8000648 TM-MMF UNII-9242ECW6R0 ZINC21297660 mycophenolate mofetil | |
| | 7 | | Gemcitabine | approved | Phase 4, Phase 3, Phase 2, Phase 1 | 2018 | 95058-81-4 | 60750 | 103882-84-4 122111-03-9 2',2'-DiF-dC 2',2'-Difluoro-2'-deoxycytidine 2',2'-Difluorodeoxycytidine 2'-Deoxy-.beta.-D-2',2'-difluorocytidine 2'-Deoxy-2',2'-difluorocytidine 4-Amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one 4-Amino-1-[3,3-difluoro-4-hydroxy-5-(hydroxymethyl) tetrahydrofuran-2-yl]-1H-pyrimidin-2-one 4-amino-1-((2R,4R,5R)-3,3-Difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one 4-amino-1-((2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one 95058-81-4 AB1004842 AC1L1TUQ C07650 CCRIS 8984 CHEBI:175901 CHEMBL888 CID60750 Cytidine, 2'-deoxy-2',2'-difluoro-2'-Deoxy-.beta.-D-2',2'-difluorocytidine D02368 DB00441 DDFC DFDC DFdC DFdCyd Folfugem GEO Gamcitabine GemLip Gemcel | Gemcin Gemcitabin Gemcitabina Gemcitabina [INN-Spanish] Gemcitabine Gemcitabine (USAN/INN) Gemcitabine HCl Gemcitabine hydrochloride Gemcitabine stereoisomer Gemcitabinum Gemcitabinum [INN-Latin] Gemtro Gemzar Gemzar (hydrochloride) HMS2089P10 HSDB 7567 Inno-D07001 LS-59139 LY 188011 LY-188011 LY188011 NCGC00168784-01 NChemBio.2007.10-comp25 NSC 613327 NSC613327 TL8005979 UNII-B76N6SBZ8R ZINC18279854 Zefei gemcitabine nchembio.573-comp7 nchembio.90-comp2 | |
| | 8 | | Tacrolimus | approved, investigational | Phase 4, Phase 3, Phase 2, Phase 1, Early Phase 1 | 1102 | 104987-11-3 | 445643, 439492 | (-)-FK 506 (3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-5,19-dihydroxy-3-{(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl}-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(prop-2-en-1-yl)-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-3H-15,19-epoxypyrido[2,1-c][1,4]oxazacyclotricosine-1,7,20,21(4H,23H)-tetrone 104987-11-3 109581-93-3 (Hydrate) 15,19-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(23H)-tetrone, 3S-[3R*[E(1S*,3S*,4S*)],4S*,5R*,8S*,9E,12R*,14R*,15S*,16R*,18S*,19S*,26aR*]]-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-5, 19-dihydroxy-3-[2-(4-hydroxy-3-methoxycyclohexyl)-1-methylethenyl]-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propenyl)-15,19-epoxy-3H-pyrido[2,1-c] [1,4] oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone 8-DEETHYL-8-[BUT-3-ENYL]-ASCOMYCIN AC-1182 AC1L1K7H AC1L97GB AC1L9IBU AKOS005145901 Advagraf Ambap104987-11-3 Ambap5429 Anhydrous tacrolimus BCBcMAP01_000194 BRD-K35452788-001-02-1 BSPBio-001279 BSPBio_001279 Bio-0921 Bio2_000470 Bio2_000950 C01375 C44H69NO10 CCRIS 7124 CHEBI:100924 CHEBI:61049 CHEMBL1200738 CID11158639 CID11556866 CID439492 CID445643 CID5372 CID5472317 CID6426916 CID6436007 CID6473866 CID6536850 CID6610362 CID6912836 CID9832283 CID9853905 CID9918805 CID9940643 CID9963169 CPD-10016 CPD000466356 D08556 DB00864 DivK1c_001040 FK 506 FK-506 FK5 FK506 FR 900506 FR-900506 | FR900506 FT-0082660 Fk-506 Fujimycin Graceptor HMS1362O21 HMS1792O21 HMS1990O21 HMS2051C18 HMS2093M19 HMS503O21 IDI1_001040 IDI1_002225 K506 KBio1_001040 KBio2_000619 KBio2_003187 KBio2_005755 KBio3_001097 KBio3_001098 KBioGR_000619 KBioSS_000619 L 679934 L-679934 LCP-Tacro LMPK04000003 LS-64247 MLS000759471 MLS001424054 Modigraf MolPort-003-666-518 NCGC00163470-01 NCGC00163470-02 NCGC00163470-03 NCGC00163470-04 NCGC00179232-01 NChemBio.2007.16-comp1 NINDS_001040 NSC717865 Prograf Prograf (TN) Protopic Protopy S5003_Selleck SAM001246677 SMR000466356 Tacarolimus Tacrolimus (INN) Tacrolimus (Prograf?) Tacrolimus (anhydrous) Tacrolimus anhydrous Tacrolimus hydrate Tacrolimus, anhydrous Tsukubaenolide UNII-Y5L2157C4J nchembio.2007.23-comp2 tacrolimus tacrolimus hydrate | |
| | 9 | | Benzocaine | approved | Phase 4, Phase 3, Phase 2, Phase 1 | 2016 | 1994-09-7, 94-09-7 | 2337 | (p-(Ethoxycarbonyl)phenylamine 06952_FLUKA 112909_ALDRICH 112909_SIAL 1333-08-0 23239-88-5 23239-88-5 (hydrochloride) 4 Aminobenzoic Acid Ethyl Ester 4-(Ethoxycarbonyl)aniline 4-(Ethoxycarbonyl)phenylamine 4-14-00-01129 (Beilstein Handbook Reference) 4-Aminobenzoate 4-Aminobenzoic acid 4-Aminobenzoic acid ethyl ester 4-Aminobenzoic acid, ethyl ester 4-Carbethoxyaniline 4-amino-benzoic acid ethyl ester 4-aminobenzoic acid ethyl ester 71123-91-6 94-09-7 94-09-7 (Parent) A0271 AB00051923 AC1L1DGC AC1Q341A AC1Q64JE AE-562/40377256 AI3-02081 AKOS000119763 AR-1H9065 Acetate, Benzocaine Aethoform Aethylium paraminobenzoicum Amben ethyl ester Americaine Anaesthan-syngala Anaesthesin Anaesthesinum Anaesthin Anestezin Anestezin [Russian] Anesthesin Anesthesine Anesthone BB_SC-0019 BPBio1_001017 BRD-K75466013-001-05-2 BRN 0638434 BSPBio_000923 BSPBio_001908 Baby Anbesol Bensokain Benzoak Benzocaina Benzocaina [INN-Spanish] Benzocaine Benzocaine (USP/INN) Benzocaine Acetate Benzocaine Formate Benzocaine Hydrobromide Benzocaine Hydrochloride Benzocaine Methanesulfonate Benzocaine [INN:BAN] Benzocainum Benzocainum [INN-Latin] Benzoic acid, 4-amino-, ethyl ester Benzoic acid, 4-amino-, ethyl ester, hydrochloride Benzoic acid, amino-, ethyl ester Benzoic acid, p-amino-, ethyl ester C07527 CAS-94-09-7 CHEBI:116735 CHEMBL278172 CID2337 Caswell No. 430A Chloraseptic D001566 D00552 DB01086 Dermoplast Diet Ayds DivK1c_000932 E1501_SIGMA EINECS 202-303-5 EPA Pesticide Chemical Code 097001 ETHYL-P-AMINOBENZOATE Ethoform Ethoforme Ethyl 4-aminobenzoate Ethyl 4-aminobenzoate hydrochloride Ethyl 4-aminobenzoic acid Ethyl Aminobenzoate Ethyl PABA | Ethyl aminobenzoate Ethyl aminobenzoate (JP15) Ethyl aminobenzoate (VAN) Ethyl aminobenzoic acid Ethyl p-Aminobenzoate Ethyl p-Aminophenylcarboxylate Ethyl p-aminobenzenecarboxylate Ethyl p-aminobenzoate Ethyl p-aminobenzoic acid Ethyl p-aminophenylcarboxylate Ethylester kyseliny p-aminobenzoove Ethylester kyseliny p-aminobenzoove [Czech] Ethylis aminobenzoas Formate, Benzocaine HMS1570O05 HMS1920G09 HMS2091M11 HMS502O14 HSDB 7225 Hurricaine Hydrobromide, Benzocaine Hydrochloride, Benzocaine I05-0204 IDI1_000932 Identhesin KBio1_000932 KBio2_000474 KBio2_003042 KBio2_005610 KBio3_001408 KBioGR_000658 KBioSS_000474 Keloform LS-35847 MLS001331704 MLS002153970 Methanesulfonate, Benzocaine MolPort-000-871-526 NCGC00016352-01 NCGC00094598-01 NCGC00094598-02 NINDS_000932 NSC 122792 NSC 41531 NSC41531 NSC4688 Norcain Norcaine Norcainum Oprea1_750694 Oprea1_827402 Ora-jel Orabase-B Orthesin Otocain Outgro Parathesin Parathesin (TN) Parathesine Prestwick0_000712 Prestwick1_000712 Prestwick2_000712 Prestwick3_000712 Prestwick_991 SMR000059025 SPBio_000134 SPBio_002844 SPECTRUM1500139 STK043620 Slim Mint Gum Solarcaine Solu H Spectrum2_000117 Spectrum3_000314 Spectrum4_000249 Spectrum5_000860 Spectrum_000074 Topcaine UNII-U3RSY48JW5 WLN: ZR DVO2 ZINC12358719 benzocaine ethylaminobenzoate-4 h-4-abz-oet nchembio.182-comp4 p-(Ethoxycarbonyl)aniline p-Aminobenzoate p-Aminobenzoic acid p-Aminobenzoic acid ethyl ester p-Aminobenzoic acid, ethyl ester p-Aminobenzoic ethyl ester p-Carbethoxyaniline p-Ethoxycarboxylic Aniline p-Ethoxycarboxylic aniline | |
| | 10 | | Mycophenolic acid | approved | Phase 4, Phase 3, Phase 2, Phase 1, Early Phase 1 | 952 | 24280-93-1 | 446541 | (e)-6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoic acid Acide mycophenolique Acido micofenolico Acidum mycophenolicum | Melbex Micofenolico acido Mycophenoic acid Mycophenolate Mycophenolsäure Myfortic |
| | 11 | | Zoledronic acid | approved | Phase 4, Phase 3, Phase 2, Phase 1 | 294 | 118072-93-8 | 68740 | (1-Hydroxy-2-imidazol-1-ylethylidene)diphosphonic acid (1-hydroxy-2-(1H-imidazol-1-yl)ethylidene)bisphosphonic acid (1-hydroxy-2-imidazol-1-yl-1-phosphonoethyl)phosphonic acid (1-hydroxy-2-imidazol-1-yl-phosphonoethyl)phosphonic acid monohydrate (1-hydroxy-2-imidazol-1-ylethylidene)diphosphonic acid 118072-93-8 2-(imidazol-1-yl)-1-hydroxyethane-1,1-diphosphonic acid 2-(imidazol-1-yl)-1-hydroxyethylidene-1,1-bisphosphonic acid AC-1092 AC1L2ACJ AC1Q6RN3 AKOS005145739 Aclasta Anhydrous Zoledronic Acid BIDD:GT0292 BIDD:PXR0134 Bio-0112 Bisphosphonate 3 C088658 CGP 42'446 CGP 42446 CGP 42446A CGP-42'446 CGP-42446 CHEBI:46557 CHEMBL924 CID68740 D08689 DB00399 | FT-0082657 HMS2089O09 I06-0710 KS-1132 LS-181815 MolPort-002-885-874 MolPort-003-850-890 NCGC00159521-02 NCGC00159521-03 NSC721517 Novartis brand of zoledronic acid Reclast Reclast (TN) S00092 S1314_Selleck UNII-70HZ18PH24 ZOL Zol Zoledronate Zoledronic Acid Anhydrous Zoledronic Acid, Anhydrous Zoledronic acid Zoledronic acid (INN) Zoledronic acid [USAN:INN] Zometa Zometa (Novartis) Zometa (TN) Zometa Concentrate Zometa, Zomera, Aclasta and Reclast, Zoledronic Acid [1-hydroxy-2-(1H-imidazol-1-yl)ethane-1,1-diyl]bis(phosphonic acid) | |
| | 12 | | Methylprednisolone | approved, vet_approved | Phase 4, Phase 3, Phase 2, Phase 1 | 1193 | 83-43-2 | 6741 | (6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one (6a,11b)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione (6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione (6α,11β)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione .DELTA.1-6.alpha.-Methylhydrocortisone 1-Dehydro-6alpha-methylhydrocortisone 1-dehydro-6alpha-Methylhydrocortisone 1-dehydro-6α-methylhydrocortisone 11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione 11beta,17,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione 11beta,17alpha,21-Trihydroxy-6alpha-methyl-1,4-pregnadiene-3,20-dione 11beta,17alpha,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione 121673-01-6 4-08-00-03498 (Beilstein Handbook Reference) 46436_FLUKA 46436_RIEDEL 570-35-4 6 Methylprednisolone 6-Methylprednisolone 6-alpha-Methylprednisolone 6.alpha.-Methylprednisolone 6923-42-8 6alpha-Methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione 6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione 6alpha-Methylprednisolone 6alpha-methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione 83-43-2 AC1L1N7A Artisone-Wyeth Artisone-wyeth BPBio1_000174 BRD-K35240538-001-03-1 BRN 2340300 BSPBio_000158 Besonia Bio-0658 CHEBI:6888 CHEMBL650 CID6741 CPD000058330 D00407 D008775 DB00959 Depo-Medrol (acetate) Dopomedrol EINECS 201-476-4 Esametone Firmacort HMS1568H20 HMS2090B13 HSDB 3127 LMST02030178 LS-118498 Lemod M0639_SIGMA M1665 MEPRDL MLS000028541 MLS001148159 MLS002207191 Medesone Medixon Medlone 21 | Medrate Medrol Medrol (TN) Medrol Adt Pak Medrol Dosepak Medrol adt pak Medrol dosepak Medrol, Solu-Medrol, Medrone, Methylprednisolone Medrone Mesopren Metastab Methyleneprednisolone Methylprednisolon Methylprednisolone Methylprednisolone (JP15/USP/INN) Methylprednisolone [USAN:INN:BAN:JAN] Methylprednisolone, 6-alpha Methylprednisolonum Methylprednisolonum [INN-Latin] Metilbetasone Metilprednisolona Metilprednisolona [INN-Spanish] Metilprednisolone Metilprednisolone [DCIT] Metilprednisolone [Dcit] Metipred Metrisone Metrocort Metysolon Moderin MolPort-002-528-554 NCGC00022735-03 NCI60_001657 NSC-19987 NSC19987 Nirypan Noretona Predni N Tablinen Prednol- L Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl- (8CI) Prestwick0_000279 Prestwick1_000279 Prestwick2_000279 Prestwick3_000279 Prestwick_622 Promacortine Reactenol S1733_Selleck SAM002589984 SMR000058330 SPBio_002377 Sieropresol Solomet Summicort Suprametil U 7532 UNII-X4W7ZR7023 Urbason Urbasone Wyacort ZINC03875560 delta(1)-6alpha-Methylhydrocortisone delta(sup 1)-6-alpha-Methylhydrocortisone methylprednisolone methylprenisolone |
| | 13 | | Pioglitazone | approved, investigational | Phase 4, Phase 1, Phase 2 | 441 | 111025-46-8 | 4829 | (+-)-5-((4-(2-(5-Ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-2,4-thiazolidinedione (+-)-5-((4-(2-(5-ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-2,4-thiazolidinedione (+/-)-5-[[4-[2-(5-Ethyl-2-pyridinyl)-ethoxy]phenyl]methyl]-2,4-thiazolidinedione (+/-)-5-[p-[2-(ethyl-2-pyridyl)ethoxy]benzyl]-2,4-thiazolidinedione 105355-27-9 111025-46-8 198077-89-3 2,4-Thiazolidinedione, 5-[[4-[2-(5-ethyl-2-pyridinyl)ethoxy]phenyl]methyl]- (9CI) 5-((4-(2-(5-Ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-2,4-thiazolidinedione 5-(4-(2-(5-ethyl-2-pyridyl)ethoxy)benzyl)-2,4-thiazolidinedione 5-[4-[2-(5-Ethyl-2-pyridyl)ethoxy]benzyl]thiazolidine-2,4-dione 5-[[4-[2-(5-Ethyl-2-pyridinyl)ethoxy]phenyl]methyl]-2,4-thiazolidinedione 5-[[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione 5-[[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]methyl]thiazolidine-2,4-dione 5-[[4-[2-[(5-ethyl-2-pyridyl)]ethoxy]phenyl]methyl]thiazolidine- 2,4-dione 5-{4-[2-(5-ethylpyridin-2-yl)ethoxy]benzyl}-1,3-thiazolidine-2,4-dione AB1004597 AC-1021 AC1L1J1Q AD 4833 AD-4833 Actos Actos (TN) Actost BRD-A48430263-003-02-4 BSPBio_002723 C07675 C19H20N2O3S CHEBI:8228 CHEMBL595 CID4829 D08378 DB01132 Duetact Glustin HMS2089H14 HS-0047 | HSDB 7322 I06-0089 KBio2_002103 KBio2_004671 KBio2_007239 KBio3_001943 KBioGR_001619 KBioSS_002103 LS-151327 MolPort-002-508-211 NCGC00163128-01 NCGC00163128-02 Pioglitazona Pioglitazona [INN-Spanish] Pioglitazone Pioglitazone HCl Pioglitazone Hydrochloride Pioglitazone [BAN:INN] Pioglitazone [Ban:Inn] Pioglitazone [INN:BAN] Pioglitazonum Pioglitazonum [INN-Latin] SPBio_001897 Spectrum2_001679 Spectrum3_001002 Spectrum4_001130 Spectrum5_001480 Spectrum5_002067 Spectrum_001623 U 72107 U 72107A U-72107 U72,107A UNII-X4OV71U42S Zactos nchembio790-comp10 pioglitazone (INN) pioglitazone HCl | |
| | 14 | | Fludarabine | approved | Phase 4, Phase 3, Phase 2, Phase 1, Early Phase 1 | 1154 | 21679-14-1, 75607-67-9 | 30751 | (2R,3S,4S,5R)-2-(6-amino-2-fluoro-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol (2R,3S,4S,5R)-2-(6-amino-2-fluoropurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol 2-F-ARAA 2-F-ara-A 2-Fluoro Ara-A 2-Fluoro-9-beta-D-arabinofuranosyladenine 2-fluoro ARA-A 21679-14-1 9-beta-D-Arabinofuranosyl-2-fluoroadenine 9-beta-D-arabinofuranosyl-2-fluoro-9H-purin-6-amine 9H-Purin-6-amine, 9-beta-D-arabinofuranosyl-2-fluoro- (9CI) AC1LCW8I AC1Q51CF C10H12FN5O4 CCRIS 3382 CHEMBL1568 CID657237 CPD000058874 D07966 EINECS 244-525-5 F-Ara-A FAMP FT-0082766 FaraA Fludara Fludara, Fludarabine | Fludarabina Fludarabina [Spanish] Fludarabine Fludarabine (INN) Fludarabine 5'-monophosphate Fludarabine [INN] Fludarabine monophosphate Fludarabine phosphate Fludarabinum Fludarabinum [Latin] Fludura Fluradosa Fluradosa (TN) HSDB 6964 I14-4978 LS-15061 MLS000028687 NSC 118218 NSC 118218H NSC-118218 S1491_Selleck SAM002548956 SMR000058874 SQ Fludarabine UNII-1X9VK9O1SC UNII-P2K93U8740 ZINC04216238 | |
| | 15 | | Iron | approved | Phase 4, Phase 3, Phase 2, Phase 1 | 1165 | 7439-89-6 | 23925 | 02583_FLUKA 12310_ALDRICH 12310_RIEDEL 129048-51-7 14067-02-8 161135-39-3 190454-13-8 195161-83-2 199281-22-6 209309_ALDRICH 209309_SIAL 255637_ALDRICH 266213_ALDRICH 266256_ALDRICH 267945_ALDRICH 267953_ALDRICH 26Fe 338141_ALDRICH 356808_ALDRICH 356824_ALDRICH 356832_ALDRICH 39344-71-3 3ZhP 413054_ALDRICH 443783-52-6 44890_ALDRICH 44890_FLUKA 675141-17-0 70884-35-4 73135-38-3 7439-89-6 8011-79-8 8053-60-9 AC1L2N38 ATW 230 ATW 432 Ancor B Ancor en 80/150 Armco iron Atomel 28 Atomel 300M200 Atomel 500M Atomel 95 Atomiron 44MR Atomiron 5M Atomiron AFP 25 Atomiron AFP 5 C00023 C3518_SIAL C3518_SIGMA CCRIS 1580 CHEBI:18248 CID23925 Carbonyl iron Copy Powder CS 105-175 D007501 DB01592 DSP 1000 DSP 128B DSP 135 DSP 135C DSP 138 Diseases (animal), iron overload Diseases, iron overload EF 1000 EF 250 EFV 200/300 EFV 250 EFV 250/400 EINECS 231-096-4 | Ed-In-Sol Eisen Electrolytic iron F 60 (metal) FE FT 3 (element) Fe Fe-40 Fe1+ Feronate Ferretts Ferro-Caps Ferro-Time Ferrousal Ferrovac E Ferrum Ferrum metallicum GS 6 HF 2 (element) HL (iron) HQ (metal) HS (iron) HS 4849 HSDB 604 Hemocyte Hierro Hoeganaes ATW 230 Hoeganaes EH IRMM524A_FLUKA IRMM524B_FLUKA IRON Iron (Fe) Iron (Fe1+) Iron ion (Fe+) Iron ion(1+) Iron monocation Iron powder Iron standard for AAS Iron(1+) Iron(1+) ion Iron(III) nitrate solution Iron, carbonyl Iron, electrolytic Iron, elemental Iron, ion (Fe1+) Iron, ion (Fe1+) (8CI,9CI) Iron, reduced LOHA LS-3196 MolPort-003-925-001 NC 100 PZh-1M3 PZh-2 PZh1M1 PZh2M PZh2M1 PZh2M2 PZh3 PZh3M PZh4M PZhO Reduced iron Remko SUY-B 2 Siderol UNII-E1UOL152H7 Vitedyn-Slo Yieronia fer ferrous iron hierro | |
| | 16 | | Emtricitabine | approved, investigational | Phase 4, Phase 3 | 457 | 143491-57-0 | 60877 | (-)-(2R,5S)-5-Fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine (-)-(2R,5S)-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine (-)-.beta.-L-FTC (-)-2',3'-Dideoxy-5-fluoro-3'-thiacytidine (-)-2'-Deoxy-5-fluoro-3'-thiacytidine (-)-FTC (-)-beta-2',3'-Dideoxy-5-fluoro-3'-thiacytidine (-)-beta-2',3'-dideoxy-5-fluoro-3'-thiacytidine (-)-cis-4-amino-5-Fluoro-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2-one (-)-cis-4-amino-5-fluoro-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2-one (2R-cis)-4-Amino-5-fluoro-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-2(1H)-pyrimidinone (2R-cis)-4-amino-5-Fluoro-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-2(1H)-pyrimidinone .beta.-L-(-)-(2R,5S)-5-Fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine 1-(2-(Hydroxymethyl)oxathiolan-5-yl)-5-fluorocytosine 143491-54-7 143491-57-0 145213-48-5 2',3',5-FTC 2',3'-Dideoxy-5-fluoro-3'-thiacytidine 2'-Deoxy-5-fluoro-3'-oxa-4'-thiocytidine 2'-Deoxy-5-fluoro-3'-thiacytidine 2-FTC 3'-Thia-2'.3'-dideoxy-5-fluorocytidine 4-Amino-5-fluoro-1-((2R,5S)-2-hydroxymethyl-[1,3]oxathiolan-5-yl)-1H-pyrimidin-2-one 4-Amino-5-fluoro-1-[(2R,5S)-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2(1H)-pyrimidinone 4-amino-5-Fluoro-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one 4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2(1H)-one 4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one 5-Fluoro-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine 5-Fluoro-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine 5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)[1,3]oxathiolan-5-yl]cytosine 524W91 AC1L1U3I AC1Q4KUB BW 1592 | BW 524W91 BW-524W91 BW524W91 C122114 C12599 C8H10FN3O3S CHEBI:31536 CHEMBL885 CID60877 Coviracil Coviracil(TM) D01199 DB00879 DRG-0208 Emtricitabin Emtricitabina Emtricitabine Emtricitabine (JAN/USAN/INN) Emtricitabinum Emtriva Emtriva (TN) Emtriva(TM) FT-0080009 HMS2089I05 HSDB 7337 LS-135838 LS-173184 NCGC00164564-01 RCV Racivir SBB066061 TL8000958 UNII-G70B4ETF4S ZINC03629271 beta-L-2',3'-dideoxy-5-fluoro-3'-thiacytidine dOTFC emtricitabine |
| | 17 | | Busulfan | approved, investigational | Phase 4, Phase 3, Phase 2, Phase 1, Early Phase 1 | 545 | 55-98-1 | 2478 | 1, 4-Dimethanesulfonoxybutane 1, 4-Dimethylsulfonoxybutane 1, {4-Bis[methanesulfonoxy]butane} 1,4-BUTANEDIOL DIMETHANESULFONATE 1,4-Bis(methanesulfonoxy)butane 1,4-Bis(methanesulfonyloxy)butane 1,4-Bis[methanesulfonoxy]butane 1,4-Butanedi yl dimethanesulfonate 1,4-Butanediol dimethanesulfonate 1,4-Butanediol dimethanesulphonate 1,4-Butanediol dimethylsulfonate 1,4-Butanediol, dimethanesulfonate 1,4-Butanediol, dimethanesulphonate 1,4-Butanediyl dimethanesulfonate 1,4-Di(methylsulfonoxy)butane 1,4-Dimesyloxybutane 1,4-Dimethane sulfonyl oxybutane 1,4-Dimethanesulfonoxybutane 1,4-Dimethanesulfonoxylbutane 1,4-Dimethanesulfonyloxybutane 1,4-Dimethanesulphonyloxybutane 1,4-Dimethylsulfonoxybutane 1,4-Dimethylsulfonyloxybutane 2041 C. B 2041 C. B. 2041 C.B 2041 C.B. 4-((Methylsulfonyl)oxy)butyl methanesulfonate 4-methylsulfonyloxybutyl methanesulfonate 55-98-1 AC-198 AC1L1DRQ AC1Q4GRQ AI3-25012 AKOS003614975 AN 33501 Ambap55-98-1 B1022 B2635_FLUKA B2635_SIGMA BRN 1791786 BSPBio_001920 BUSULFAN (1,4-BUTANEDIOL, DIMETHANESULFONATE) Bisulfex Busilvex Busulfan Busulfan (JP15/USP/INN) Busulfan GlaxoSmithKline Brand Busulfan Orphan Brand Busulfan Wellcome Busulfan Wellcome Brand Busulfan [INN:JAN] Busulfano Busulfano [INN-Spanish] Busulfanum Busulfanum [INN-Latin] Busulfex Busulphan Busulphane Butanedioldimethanesulfonate Buzulfan C.B. 2041 C6H14O6S2 CB 2041 CCRIS 418 CHEBI:28901 CHEMBL820 CID2478 CPD000058613 Citosulfan D002066 D00248 DB01008 DivK1c_000847 EINECS 200-250-2 FT-0083567 G.T. 41 GT 2041 GT 41 Glaxo Wellcome Brand of Busulfan GlaxoSmithKline Brand of Busulfan Glyzophrol HMS1920I07 HMS2091O09 HMS502K09 | HSDB 7605 I09-1371 IDI1_000847 InChI=1/C6H14O6S2/c1-13(7,8)11-5-3-4-6-12-14(2,9)10/h3-6H2,1-2H3 KBio1_000847 KBio2_000512 KBio2_003080 KBio2_005648 KBio3_001420 KBioGR_000698 KBioSS_000512 LS-1358 Leucosulfan MLS001076666 MYLERAN (TN) Mablin Methanesulfonic Methanesulfonic acid, tetram ethylene ester Methanesulfonic acid, tetramethylene ester Mielevcin Mielosan Mielucin Milecitan Mileran Misulban Mitosan Mitostan MolPort-001-783-406 Myeleukon Myeloleukon Myelosan Myelosanum Mylecytan Myleran Myleran Tablets Myleran tablets Myleran, Busulfex, Busulfan Mylerlan NCGC00090905-01 NCGC00090905-02 NCGC00090905-03 NCGC00090905-04 NCGC00090905-05 NCGC00090905-06 NCGC00090905-07 NCI-C01592 NCI60_041640 NCIMech_000192 NINDS_000847 NSC 750 NSC-750 NSC-750sulphabutin NSC750 Orphan Brand of Busulfan Prestwick_989 S1692_Selleck SAM002554887 SMR000058613 SPBio_000253 SPECTRUM1500152 ST50825921 Spectrum2_000067 Spectrum3_000320 Spectrum4_000259 Spectrum5_000928 Spectrum_000092 Sulfabutin Sulfabutin (VAN) Sulphabutin Tetramethylene Dimethane Sulfonate Tetramethylene bis(methanesulfonate) Tetramethylene bis[methanesulfonate] Tetramethylene dimethane sulfonate Tetramethylene {bis[methanesulfonate]} Tetramethylenester Kyseliny Methansulfonove Tetramethylenester kyseliny methansulfonove Tetramethylenester kyseliny methansulfonove [Czech] UNII-G1LN9045DK WLN: WS1&O4OSW1 Wellcome Brand of Busulfan Wellcome, Busulfan X 149 acid, tetramethylene ester alkylating agent: crosslinks guanine residues busulfan butane-1,4-diyl dimethanesulfonate n-Butane-1,3-di(methylsulfonate) |
| | 18 | | Cisplatin | approved | Phase 4, Phase 3, Phase 2, Phase 1, Early Phase 1 | 2770 | 15663-27-1 | 84093, 441203, 2767 | (SP-4-1)-diamminedichloridoplatinum (SP-4-1)-diamminedichloroplatinum (SP-4-2)-diamminedichloridoplatinum (SP-4-2)-diamminedichloroplatinum Abiplatin Biocisplatinum Briplatin CACP CDDP CHEBI:35852 CID441203 CPD0-1392 CPDC CPDD Carboquone Cis Pt II Cis-DDP Cis-Diaminedichloroplatinum Cis-Diamminedichloroplatinum Cismaplat Cisplatine Cisplatino Cisplatinum Cisplatyl Citoplationo DB00515 DDP DDPT Diamminedichloroplatinum | EU-0100918 Lederplatin Neoplatin Peyrone's chloride Peyrone's salt Plastin Platamine Platiblastin Platidiam Platinex Platinol Platinol-AQ Platinoxan Platinum Ammine Chloride Platinum Ammonium Chloride Platinum Diamine Dichloride Randa Trans-DDP Trans-Diaminedichloroplatinum Trans-Diamminedichloroplatinum Trans-Dichlorodiammine Platinum Trans-Platinumdiammine Dichloride cis-DDP cis-Diamminedichloroplatinum cis-Dichlorodiammineplatinum(II) cis-[PtCl2(NH3)2] cis-diamminedichloridoplatinum(II) cis-diamminedichloroplatinum(II) nchembio773-comp1 trans-diamminedichloridoplatinum(II) | |
| | 19 | | Acetylcysteine | approved, investigational | Phase 4 | 330 | 616-91-1 | 12035 | (2R)-2-acetylamino-3-sulfanylpropanoic acid (R)-2-acetylamino-3-mercaptopropanoic acid (R)-mercapturic acid 2-Acetylamino-3-mercapto-propionate 2-Acetylamino-3-mercapto-propionic acid ACC Acetadote Acetilcisteina Acetylcysteine Acetylcysteinum Fluimicil Infantil Fluimucetin Fluimucil Flumucetin Fluprowit | L-Acetylcysteine L-acetylcysteine L-α-acetamido-β-mercaptopropionic acid Lysox Mercapturic acid Mucolysin Mucomyst N-Acety-L-Cysteine N-Acetyl-3-mercaptoalanine N-Acetyl-L-(+)-cysteine N-Acetylcysteine N-acetyl-L-(+)-cysteine N-acetyl-L-cysteine N-acetylcysteine NAC Parvolex Sodium 2-acetamido-3-mercaptopropionate |
| | 20 | | Thiotepa | approved | Phase 4, Phase 2, Phase 1 | 226 | 52-24-4 | 5453 | | | 21 | | Tenofovir | approved, investigational | Phase 4, Phase 3 | 759 | 147127-20-6 | 464205 | (R)-9-(2-Phosphonomethoxypropyl)adenine (R)-9-(2-Phosphonylmethoxypropyl)adenine (R)-9-(2-phosphonomethoxypropyl)adenine (R)-PMPA 147127-20-6 206184-49-8 AC-760 AC1LA9BO Anh. tenofovir Anhydrous tenofovir Apropovir CHEBI:45809 CHEMBL483 CID464205 D,L-Tenofovir DB00300 GNA & Tenofovir GS 1275 GS 1278 GS1278 | HHA & Tenofovir KS-5021 MolPort-003-850-411 NCGC00167535-01 PMPA PMPA-(R) Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]- & Galanthus nivalis agglutinin (GNA) Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]- & Hippeastrum hybrid agglutinin( HHA) Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]- (9CI) Phosphonic acid, [[2-(6-amino-9H-purin-9 S1401_Selleck TDF TFV Tenefovir Tenofovir Tenofovir (anh.) Tenofovir disoproxil Tenofovir disoproxil fumarate UNII-99YXE507IL Viread Viread, Tenofovir [(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethylphosphonic acid |
| | 22 | | Prednisolone | approved, vet_approved | Phase 4, Phase 3, Phase 2, Phase 1 | 1193 | 50-24-8 | 5755 | (11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione .DELTA.1-Cortisol .DELTA.1-Dehydrocortisol .DELTA.1-Dehydrohydrocortisone .DELTA.1-Hydrocortisone .delta.-Cortef .delta.-Stab 1,2-Dehydrohydrocortisone 1,4-Pregnadiene-11beta,17alpha,21-triol-3,20-dione 1,4-Pregnadiene-3,20-dione-11beta,17alpha,21-triol 1-Dehydrocortisol 1-Dehydrohydrocortisone 3,20-dioxo-11beta,17alpha,21-Trihydroxy-1,4-pregnadiene 46656_FLUKA 46656_RIEDEL 50-24-8 58201-11-9 8056-11-9 AC-1773 AC1L1L2E Ak-Pred Ak-Tate Alphadrol Articulose-50 BPBio1_000164 BRD-K98039984-001-03-0 BRN 1354103 BSPBio_000148 Bio-0666 Bubbli-Pred C07369 CCRIS 980 CHEBI:8378 CHEMBL131 CID5755 CO-Hydeltra CPD000718761 Co-Hydeltra Codelcortone Cordrol Cortalone Cotogesic Cotolone D00472 D011239 DB00860 Decaprednil Decortin H Delcortol Delta F Delta(1)-dehydrohydrocortisone Delta-Cortef Delta-Cortef (TN) Delta-Ef-Cortelan Delta-Stab Delta-stab Deltacortenol Deltacortril Deltacortril Enteric Deltahydrocortisone Deltasolone Deltisilone Depo-Medrol Derpo PD Derpo Pd Dexa-Cortidelt Hostacortin H Dexa-Cortidelt hostacortin H Di Adreson F Di-Adreson F Di-Adreson-F Di-adreson F DiAdresonF Dicortol Donisolone Dydeltrone EINECS 200-021-7 Eazolin D Econopred Econopred Plus Erbacort Erbasona Estilsona Fernisolone Fernisolone P Fernisolone-P Flamasone HMS1568H10 HMS2090J05 HSDB 3385 Hostacortin H Hydeltra Hydeltra-Tba Hydeltrasol Hydeltrone Hydrodeltalone Hydrodeltisone Hydroretrocortin Hydroretrocortine I-Pred Inflamase Forte Inflamase Mild K 1557 Key-Pred Klismacort LMST02030179 LS-7669 Lentosone Lite Pred M-Predrol | MLS001304083 MLS002154250 MLS002207037 Medrol Medrol Acetate Metacortandralone Methylprednisolone Acetate Meti-Derm Meticortelone Metreton MolPort-002-507-147 NCGC00179649-01 NSC 9120 NSC9120 NSC9900 Neo-Delta-Cortef Nisolone Nor-Pred T.B.A. Ocu-Pred Ocu-Pred Forte Ophtho-Tate Orapred P0152_SIGMA P0637 P6004_SIGMA PRDL PRED-G Panafcortelone Paracortol Paracotol Pediapred Poly-Pred Precortalon Precortancyl Precortilon Precortisyl Pred Forte Pred Mild Predair Predair A Predair Forte Predalone 50 Predalone T.B.A. Predate Predate Tba Predate-50 Predcor-25 Predcor-50 Predcor-Tba Predisolone Sodium Phosphate Predne-Dome Prednelan Predni-Dome Prednicen Predniliderm Predniretard Prednis Prednisolona Prednisolona [INN-Spanish] Prednisolone (JP15/USP/INN) Prednisolone (anhydrous) Prednisolone Acetate Prednisolone Sodium Phosphate Prednisolone Tebutate Prednisolone [INN:BAN:JAN] Prednisolonum Prednisolonum [INN-Latin] Predonin Predonine Prelone Prenolone Prestwick0_000274 Prestwick1_000274 Prestwick2_000274 Prestwick3_000274 Prestwick_404 Rolisone S1737_Selleck SAM002264639 SMR000718761 SPBio_002367 Scherisolon Solone Steran Sterane Sterolone Supercortisol UNII-9PHQ9Y1OLM Ulacort Ultra Pred Ultracorten H Ultracortene H Ultracortene-H Ultracortene-Hydrogen Ultracortene-hydrogen ZINC03833821 component of Ataraxoid component of K-Predne-Dome delta(1)-Cortisol delta(1)-Dehydrocortisol delta(1)-Dehydrohydrocortisone delta(1)-Hydrocortisone delta(sup 1)-Cortisol delta(sup 1)-Dehydrocortisol delta(sup 1)-Dehydrohydrocortisone delta(sup 1)-Hydrocortisone delta-dehydrocortisol delta-dehydrohydrocortisone delta-hydrocortisone prednisolone | |
| | 23 | | Oxaliplatin | approved, investigational | Phase 4, Phase 3, Phase 2, Phase 1 | 1460 | 61825-94-3 | 5310940, 9887054, 6857599, 9887054, 43805 | CHEMBL1201055 CID9887054 D01790 DACPLAT Diaminocyclohexane Oxalatoplatinum Eloxatin Eloxatin (TN) Elplat Foloxatine L-OHP Oxalatoplatin | Oxalatoplatinum Oxaliplatin (JAN/USAN/INN) Oxaliplatin [Usan:Inn:Ban] Oxaliplatino [Spanish] Oxaliplatinum [Latin] Oxaloplatine [French] Oxaloplatino [Spanish] Transplatin oxaliplatin oxaliplatine oxaliplatino oxaliplatinum | |
| | 24 | | Vincristine | approved, investigational | Phase 4, Phase 3, Phase 2, Phase 1 | 922 | 2068-78-2, 57-22-7 | 5978 | 22-Oxovincaleukoblastin 22-Oxovincaleukoblastine 28379-27-3 57-22-7 AC1L1LJC C07204 C46H56N4O10 CCRIS 5763 CHEBI:28445 CID5978 D08679 DB00541 EINECS 200-318-1 HMS2090E19 HSDB 3199 Indole alkaloid LCR LS-228 Leurocristine Lilly 37231 (1:1 sulfate salt) Liposomal Vincristine Marqibo NCGC00163700-01 NCI-C04864 NCI60_026703 NSC-67574 Onco TCS | Oncovin Oncovin (1:1 sulfate salt) Oncovine Tecnocris Tecnocris (TN) UNII-5J49Q6B70F VCR VIN Vincaleukoblastine, 22-oxo- 22-Oxovincaleukoblastine Vincasar Vincasar (1:1 sulfate salt) Vincasar PFS Vincrex Vincrex (1:1 sulfate salt) Vincristin Vincristina Vincristina [DCIT] Vincristine (INN) Vincristine Sulfate Vincristine Sulfate PFS Vincristine [INN:BAN] Vincristinum Vincristinum [INN-Latin] Vincrstine Vincrystine Vinkristin Z-D-Val-Lys(Z)-OH vincristine | |
| | 25 | | Etoposide | approved | Phase 4, Phase 3, Phase 2, Phase 1, Early Phase 1 | 1269 | 33419-42-0 | 36462 | (-)-Etoposide 121471-01-0 136598-18-0 201594-04-9 33419-42-0 35317-32-9 4'-Demethyl-epipodophyllotoxin 9-[4,6-O-(R)-ethylidene-beta-D-glucopyranoside 4'-Demethylepipodophyllotoxin 9-(4,6-O-(R)-ethylidene-beta-D-glucopyranoside) 4'-Demethylepipodophyllotoxin 9-(4,6-O-ethylidene-beta-D-glucopyranoside) 4'-Demethylepipodophyllotoxin ethylidene-.beta.-D-glucoside 4'-O-Demethyl-1-O-(4,6-O-ethylidene-beta-D-glucopyranosyl)epipodophyllotoxin 4-Demethylepipodophyllotoxin beta-D-ethylideneglucoside 4-Demethylepipodophyllotoxin-.beta.-D-ethylideneglucoside 51854-34-3 76576-58-4 9-((4,6-O-Ethylidine-beta-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,4-dimethyloxyphenyl)furo(3',4'':6,7)naptho-(2,3-D)-1,3-dioxol-6(5ah)-one AB00438905 AC1L1FN8 AC1L1VT3 AC1L6246 AC1NR4OG AC1O4WGG AC1O7M1N AC1Q47JJ Ambap33419-42-0 BPBio1_000673 BRD-K37798499-001-02-5 BSPBio_000611 Bio1_000489 Bio1_000978 Bio1_001467 C01576 CCRIS 2392 CHEBI:4911 CHEBI:588795 CHEMBL44657 CID11758093 CID284997 CID3310 CID36462 CID5284558 CID6419930 CID6610299 CPD000112002 D00125 DB00773 DEMETHY-EPIPODOPHYLLOTOXIN,ETHYLIDENE GLUCOSIDE, Demethyl Epipodophyllotoxin Ethylidine Glucoside Demethyl-epiodophyllotoxin ethylidene glucoside Demethylepipodophyllotoxin-beta-D-ethylideneglucoside E0675 E1383_SIGMA EINECS 251-509-1 EPE EPEG ETOP Epipodophyllotoxin Epipodophyllotoxin VP-16213 Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-.beta.-D-glucopyranoside Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-beta-D-glucopyranoside Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-beta-D-glucopyranoside (8CI) Epipodophyllotoxin, 4'-demethyl-, 9-(4,6-O-ethylidene-.beta.-D-glucopyranoside) Epipodophyllotoxin, 4'-demethyl-, 9-(4,6-O-ethylidene-beta-D-glucopyranoside) Eposide Eposin | Eposin, Vepesid, VP-16, Toposar, Etoposide Etopol Etopophos Etopophos (phosphate salt) Etoposid Etoposide Etoposide (JP15/USP/INN) Etoposide (VP16) Etoposide [USAN:INN:BAN:JAN] Etoposido Etoposido [INN-Spanish] Etoposidum Etoposidum [INN-Latin] Etosid HMS1569O13 HMS2052N05 HMS2089F14 HSDB 6517 I06-0248 KBioSS_002410 LS-1214 Lastet MLS000049957 MLS001074951 MLS001424283 MLS002153463 MLS002207239 MLS002222184 MolPort-003-983-431 MolPort-004-905-001 MolPort-004-955-161 NCGC00025056-02 NChemBio.2007.10-comp19 NK 171 NSC 141540 NSC-141540 NSC141540 Prestwick0_000396 Prestwick1_000396 Prestwick2_000396 Prestwick3_000396 Prestwick_211 S1225_Selleck SAM001246880 SMR000112002 SPBio_002532 ST056353 Toposar UNII-6PLQ3CP4P3 VP 16 VP 16 (pharmaceutical) VP 16-213 VP 16213 VP-16 VP-16-213 VePESID (TN) VePesid Vepesid Vepesid J Vepeside ZINC03830818 ZINC03938684 Zuyeyidal etoposide nchembio.573-comp8 nchembio873-comp2 trans-Etoposide |
| | 26 | | Everolimus | approved | Phase 4, Phase 3, Phase 2, Phase 1, Early Phase 1 | 1940 | 159351-69-6 | 6442177 | (1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.0(sup 4,9))hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone (1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.04,9)hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone (1R,9S,12S,15R,16E,23S,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.0(sup 4,9))hexatriacont (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-23,27-epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(2R)-1-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]propan-2-yl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34as)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethy 07741_FLUKA 159351-69-6 40-O-(2-hydroxyethyl)-rapamycin 42-O-(2-Hydroxyethyl)rapamycin Afinitor CERTICAN(R) CHEMBL1201755 Certican D02714 DB01590 | Everolimus Everolimus (JAN/USAN/INN) Everolimus [USAN] LS-143292 MolPort-003-847-342 MolPort-003-925-588 NCGC00167512-01 NVP-RAD-001 RAD 001 RAD-001 RAD-001C RAD001 RAD001, SDZ-RAD, Certican, Zortress, Afinitor, Everolimus S1120_Selleck SDZ-RAD UNII-9HW64Q8G6G Zortress everolimus |
| | 27 | | Vidarabine | approved | Phase 4, Phase 3, Phase 2, Phase 1, Early Phase 1 | 521 | 24356-66-9 | 32326, 21704 | (+)-Cyclaradine .beta.-Adenosine .beta.-D-Adenosine 1odi 2-(6-AMINO-purin-9-yl)-5-hydroxymethyl-tetrahydro-furan-3,4-diol 2946-52-3 2fqy 2gl0 30143-02-3 3080-29-3 3228-71-5 4005-33-8 46946-45-6 46969-16-8 524-69-6 5536-17-4 58-61-7 9-Arabinosyladenine 9-beta-D-Arabinofuranosyl-9H-purin-6-amine 9-beta-D-Arabinofuranosyl-adenine 9-beta-D-Arabinofuranosyladenine 9-beta-D-arabinofuranosyl-adenine 9-β-D-arabinofuranosyl-9H-purin-6-amine 9-β-D-arabinofuranosyladenine A 9251 A0152 A4036_SIGMA A4676_SIGMA A5762_SIGMA A9251_SIGMA AC1L18OL AC1L1U8O AC1L2IWM AC1L2SCM AC1O4WIN AC1O8PY7 AC1Q1ID3 AC1Q4Y1Z AC1Q52XU ADENOSINE, U.S.P. ADN AI3-52413 AI3-52821 AR-1H6029 ARA-A NSC 247519 Ade-Rib Adenine Arabinoside Adenine arabinoside Adenine nucleoside Adenine riboside Adenine xyloside Adenocard Adenocard (TN) Adenocard, Adenosine Adenocor Adenoscan Adenoscan (TN) Adenosin Adenosin [German] Adenosine (JAN/USP) Adenosine [USAN:BAN] Adenosine arabinose Adenosine-8-14C Adensoine Ambap5536-17-4 Ara A Ara-A Ara-ATP Araadenosine Arabinoside Adenine Arabinoside adenine Arabinosyl Adenine Arabinosyl adenine Arabinosyl-adenine Arabinosyladenine Arasena-A Armes Armes (TN) BB_NC-0565 BPBio1_000898 BRN 0624881 BSPBio_000816 BSPBio_001796 BSPBio_002000 Bio1_000437 Bio1_000926 Bio1_001415 Boniton C00212 CAS-5536-17-4 CCRIS 2557 CCRIS 3383 CHEBI:136932 CHEBI:16335 CHEBI:45327 CHEMBL1090 CHEMBL20247 CHEMBL477 CI 673 CI-673 CID102198 CID191 CID21704 CID60961 CID6420052 CID6713976 CPD000471872 Caswell No. 010B D000241 D00045 D06298 DB00640 DivK1c_000191 EINECS 200-389-9 EINECS 217-911-6 EINECS 226-893-9 EU-0100123 FT-0082881 HMS1570I18 HMS1920A13 HMS1921K05 HMS2090F06 HMS2091G13 HMS2092C16 HMS500J13 HSDB 6514 | I01-1121 IDI1_000191 KBio1_000191 KBio2_002418 KBio2_004986 KBio2_007554 KBio3_001296 KBio3_001500 KBioGR_001224 KBioSS_002424 L000094 LS-15059 LS-15085 Lopac0_000123 MEDR-640 MLS000069638 MLS000699527 MLS001066352 MLS001333133 MLS001333134 MLS002153227 MLS002153992 MolPort-001-785-903 MolPort-001-838-229 MolPort-003-666-308 Myocol NCGC00016656-01 NCGC00023673-03 NCGC00023673-04 NCGC00023673-05 NCGC00023673-06 NCGC00023673-07 NCGC00094579-01 NCGC00094579-02 NCGC00094579-03 NCGC00094579-04 NCGC00178869-01 NCGC00179417-01 NCI60_003823 NCI60_037192 NCIOpen2_003303 NCIOpen2_005376 NINDS_000191 NSC 247519 NSC 404241 NSC 627048 NSC 7359 NSC 7652 NSC-404241 NSC247519 NSC404241 NSC627048 NSC70422 NSC7359 NSC7652 NSC80832 NSC87676 NSC91041 Nucleocardyl PDSP1_001036 PDSP2_001020 Pallacor Polyadenosine Polyriboadenosine Prestwick0_000768 Prestwick1_000768 Prestwick2_000768 Prestwick3_000768 Prestwick_983 RAB S1647_Selleck S1784_Selleck SAM002564191 SMP1_000312 SMR000058216 SMR000225041 SMR000471872 SMR001233326 SPBio_001194 SPBio_001491 SPBio_002755 SPECTRUM1500107 SPECTRUM1500609 SR 96225 SR-96225 STK361815 SUN-Y4001 Sandesin Spectrum2_001257 Spectrum2_001336 Spectrum3_000288 Spectrum3_000580 Spectrum4_000782 Spectrum5_001429 Spectrum_001894 Spongoadenosine TL8003749 UNII-3XQD2MEW34 UNII-K72T3FS567 USAF CB-10 V0098 VIRDARABINE Vidarabin Vidarabina Vidarabina [DCIT] Vidarabine Vidarabine (JAN) Vidarabine anhydrous Vidarabinum Vira ATM Vira-A Vira-A, Vidarabine XA Xylosyl A Xylosyladenine ZINC00970363 ZINC02169830 adenine-D-ribose adenosine alpha-Ara A beta-Adenosine beta-Ara A beta-D-Adenosine bmse000061 nchembio.143-comp9 nchembio.186-comp109 nchembio.64-comp4 nchembio706-5 |
| | 28 | | Dexamethasone | approved, investigational, vet_approved | Phase 4, Phase 3, Phase 2, Phase 1, Early Phase 1 | 2171 | 50-02-2 | 5743 | (3H)-Dexamethasone .delta.(sup 1)-9-.alpha.-Fluoro-16-.alpha.-methylcortisol .gamma.corten 1-Dehydro-16.alpha.-methyl-9.alpha.-fluorohydrocortisone 1-Dehydro-16alpha -methyl-9alpha -fluorohydrocortisone 1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone 1-Dehydro-16α-methyl-9α-fluorohydrocortisone 137098-19-2 16-alpha-Methyl-9-alpha-fluoro-1-dehydrocortisol 16-alpha-Methyl-9-alpha-fluoro-delta(sup 1)-hydrocortisone 16-alpha-Methyl-9-alpha-fluoro-delta1-hydrocortisone 16-alpha-Methyl-9-alpha-fluoroprednisolone 16.alpha.-Methyl-9.alpha.-fluoro-1-dehydrocortisol 16.alpha.-Methyl-9.alpha.-fluoroprednisolone 16alpha -Methyl-9alpha -fluoro-1-dehydrocortisol 16alpha -Methyl-9alpha -fluoroprednisolone 16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol 16alpha-Methyl-9alpha-fluoro-delta(sup 1)-hydrocortisone 16alpha-Methyl-9alpha-fluoroprednisolone 16α-Methyl-9α-fluoro-1-dehydrocortisol 23495-06-9 31375_FLUKA 46165_FLUKA 46165_RIEDEL 50-02-2 8054-59-9 9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione 9-Fluoro-11alpha -methylpregna-1,4-diene-3,20-dione 9-Fluoro-16-methylprednisolone 9-alpha-Fluoro-16-alpha-methylprednisolone 9.alpha.-Fluoro-16.alpha.-methylprednisolone 906422-84-2 9A-FLUORO-16BETA-METHYLPREDNISOLONE 9alpha -Fluoro-16alpha -methylprednisolone 9alpha-Fluoro-16alpha-methylprednisolone 9alpha-fluoro-16alpha-methyl-Prednisolone 9α-Fluoro-16α-methylprednisolone AC-11056 AC1L1L1H AC1Q29DM AI3-50934 Adexone Aeroseb-D Aeroseb-Dex Aeroseb-dex Ak Dex Oph Otic Soln 0.1% Alcon Brand of Dexamethasone Anaflogistico Aphtasolon Aphthasolone Apo-dexamethasone Auxiron Azimycin (veterinary) Azium Azium (Veterinary) Azium (veterinary) BIDD:ER0494 BIDD:PXR0060 BRD-K38775274-001-02-3 BRD-K38775274-001-06-4 BSPBio_000995 Bisu DS Bisu Ds C15643 C22H29FO5 CCRIS 7067 CHEBI:41879 CHEMBL384467 CID5743 CPD-10549 CPD001227192 Calonat Corson Corsone Cortisumman D00292 D003907 D1756_SIGMA D4902_SIGMA D6645_SIGMA D8893_SIGMA D9184_SIGMA DB01234 DEX DEXA DEXONE 0.5 DEXONE 0.75 DEXONE 1.5 DEXONE 4 DXM DXMS Decacort Decacortin Decaderm Decadron Decadron (TN) Decadron Tablets, Elixir Decadron, Dexamethasone Decadron-LA Decadron-La Decagel Decaject Decaject L.A. Decaject-L.A. Decalix Decameth Decasone Decaspray Dectancyl Dekacort Delta1-9alpha-Fluoro-16alpha-methylcortisol Deltafluorene Dergramin Deronil Desadrene Desametasone Desametasone [DCIT] Desametasone [Dcit] Desamethasone Desameton Deseronil Dex-Ide Dex-ide Dexa Dexa Mamallet Dexa mamallet Dexa-Cortidelt Dexa-Cortisyl Dexa-Mamallet Dexa-Scheroson Dexa-Sine Dexa-cortidelt Dexa-cortisyl Dexa-scheroson Dexa-sine Dexacen-4 Dexacidin Dexacort Dexacortal Dexacortin Dexadeltone Dexafarma Dexair Dexalona Dexaltin Dexametasona Dexametasona [INN-Spanish] Dexametasone | Dexameth Dexamethansone Dexamethasone Dexamethasone (JP15/USP/INN) Dexamethasone Acetate Dexamethasone Alcohol Dexamethasone Base Dexamethasone Intensol Dexamethasone Sodium Phosphate Dexamethasone [INN:BAN:JAN] Dexamethasone alcohol Dexamethasone base Dexamethasone intensol Dexamethasone-omega Dexamethasonum Dexamethasonum [INN-Latin] Dexamethazone Dexamonozon Dexapolcort Dexapos Dexaprol Dexason Dexasone Dexasone 0.5mg Dexasone 0.75mg Dexasone 4mg Dexasporin Dexinolon Dexinoral Dexone Dexone 0.5 Dexone 0.75 Dexone 1.5 Dexone 4 Dexonium Dexpak Dextelan Dezone Dinormon Dxms ECR Brand of Dexamethasone EINECS 200-003-9 FT-0080377 Fluormethylprednisolone Fluormone Fluorocort Fortecortin Foy Brand of Dexamethasone Gammacorten HL-dex HMS1792A17 HMS1990A17 HMS2089N13 HSDB 3053 Hexadecadrol Hexadrol Hexadrol Elixir Hexadrol Tablets Hexadrol elixir Hl-Dex Hl-dex I06-1196 ICN Brand of Dexamethasone IontoDex Isopto-Dex Isopto-dex LS-7300 Lokalison F Lokalison f Loverine Luxazone MK 125 MLS001055412 MLS001332507 MLS001332508 Maxidex Maxidex Ont 0.1% Maxidex Sus 0.1% Maxitrol Mediamethasone Merck Brand of Dexamethasone Merz Brand 1 of Dexamethasone Merz Brand 2 of Dexamethasone Methylfluorprednisolone Mexidex Millicorten MolMap_000018 MolPort-003-846-433 Mymethasone NCGC00091019-01 NCGC00091019-02 NCGC00091019-03 NCGC00091019-04 NCGC00091019-05 NCI60_003067 NSC 34521 NSC34521 Naquasone (veterinary) Neomycin and polymyxin b sulfates and dexamethasone Neomycin and polymyxin b sulphates and dexamethasone OTO-104 Ocu-Trol Ocu-trol Oradexon PHL-dexamethasone PMS-dexamethasone Pet Derm III Pet Derm Iii Pet derm III Pet-Derm Iii Pms Dexamethasone Elixir 0.5mg/5ml Policort Posurdex Prednisolon F Prednisolon f Prednisolone F Prednisolone f Prodex S1322_Selleck SAM002548948 SGCUT00126 SK-Dexamethasone SK-dexamethasone SMP1_000092 SMR000857119 SMR001227192 ST50307091 Sandoz dexamethasone Sk-Dexamethasone Spectrum5_002019 Spoloven Sunia Sol D Sunia sol D Superprednol TL8003317 Tobradex Tobramycin and dexamethasone Tresaderm (veterinary) Turbinaire UNII-7S5I7G3JQL Visumetazone WLN: L E5 B666 OV KU MUTJ A1 BF CQ E1 FV1Q FQ G1 ZINC03875332 alpha -Fluoro-16-alpha -methylcortisol delta(Sup 1)-9-alpha-Fluoro-16-alpha-methylcortisol delta(sup 1)-9-alpha-Fluoro-16-alpha-methylcortisol delta1-9alpha-Fluoro-16alpha-methylcortisol dexamethasone nchembio809-comp2 to_000038 |
| | 29 | | Cyclophosphamide | approved, investigational | Phase 4, Phase 3, Phase 2, Phase 1, Early Phase 1 | 2935 | 50-18-0, 6055-19-2 | 2907 | (+-)-Cyclophosphamide (-)-Cyclophosphamide (RS)-Cyclophosphamide 1-(bis(2-chloroethyl)amino)-1-oxo-2-aza-5-oxaphosphoridine 1-Bis(2-chloroethyl)amino-1-oxo-2-aza-5-oxaphosphoridin 2-[Bis(2-chloroethylamino)]-tetrahydro-2H-1,3,2-oxazaphosphorine-2-oxide 4-Hydroxy-cyclophosphan-mamophosphatide 50-18-0 60007-95-6 6055-19-2 (monohydrate) 75526-90-8 AC1L1EQQ AI3-26198 ASTA ASTA B518 Anhydrous cyclophosphamide Asta B 518 B 518 B-518 BRN 0011744 BSPBio_002099 Bis(2-chloroethyl)phosphoramide cyclic propanolamide ester C 0768 C07888 C7H15Cl2N2O2P CB 4564 CB-4564 CCRIS 188 CHEBI:4027 CHEMBL32520 CHEMBL88 CID2907 CP CPA CTX CY Ciclofosfamida Ciclofosfamida [INN-Spanish] Ciclofosfamide Ciclophosphamide Ciclophosphamide [INN] Clafen Claphene Cycloblastin Cyclophosphamid Cyclophosphamide Cyclophosphamide (INN) Cyclophosphamide (TN) Cyclophosphamide (anhydrous form) Cyclophosphamide (anhydrous) Cyclophosphamide Monohydrate Cyclophosphamide Sterile Cyclophosphamide anhydrous Cyclophosphamide, (+-)-Isomer Cyclophosphamides Cyclophosphamidum Cyclophosphamidum [INN-Latin] Cyclophosphan Cyclophosphane Cyclophosphanum Cyclophosphoramide Cyclostin Cyklofosfamid Cyklofosfamid [Czech] Cytophosphan Cytophosphane Cytoxan Cytoxan (TN) Cytoxan Lyoph D,L-Cyclophosphamide D07760 | DB00531 DivK1c_000246 EINECS 200-015-4 EU-0100238 Endoxan Endoxan R Endoxan-Asta Endoxana Endoxanal Endoxane Enduxan Genoxal HMS2090A12 HSDB 3047 Hexadrin IDI1_000246 KBio1_000246 KBio2_001338 KBio2_003906 KBio2_006474 KBio3_001319 KBioGR_000888 KBioSS_001338 LS-1302 LS-99787 Ledoxina Lopac-C-0768 Lopac0_000238 Lyophilized Cytoxan Mitoxan MolPort-001-783-420 N,N-Bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide N,N-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide NCGC00015209-01 NCGC00015209-03 NCGC00015209-06 NCGC00091741-02 NCGC00091741-03 NCI-C04900 NCI60_002097 NINDS_000246 NSC 26271 NSC-26271 NSC26271 NSC273033 NSC273034 Neosar Occupation, cyclophosphamide exposure Procytox RCRA waste no. U058 Rcra Waste Number U058 Rcra waste number U058 Revimmune S1217_Selleck SK 20501 SPBio_001071 STK177249 STOCK2S-91217 Semdoxan Sendoxan Senduxan Spectrum2_001146 Spectrum3_000370 Spectrum4_000304 Spectrum5_000795 Spectrum_000858 UNII-6UXW23996M WLN: T6MPOTJ BO BN2G2G Zyklophosphamid Zyklophosphamid [German] bis(2-Chloroethyl)phosphami de cyclic propanolamide bis(2-Chloroethyl)phosphamide cyclic propanolamide ester cyclophosphamide |
| | 30 | | Miconazole | approved, investigational, vet_approved | Phase 4, Phase 3, Phase 2, Phase 1, Early Phase 1 | 3706 | 22916-47-8 | 4189 | (+-)-1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole 1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole 1-(2,4-dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl) imidazole 1-[2,4-Dichloro- beta-([2,4-dichloro- benzyl]oxy)phenethyl]imidazole 1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole 1-[2-(2,4-Dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-1H-imidazole 1-[2-(2,4-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole 1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole 1-[2-(2,4-dichlorophenyl)-2-{[(2,4-dichlorophenyl)methyl]oxy}ethyl]-1H-imidazole 1-{2-[(2,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole 22832-87-7 (NITRATE) 22916-47-8 75319-47-0 AB00053500 AC1L1HM1 AKOS001574474 Aflorix(nitrate) Albistat(nitrate) Andergin(nitrate) BPBio1_000279 BRD-A82396632-001-03-0 BRD-A82396632-008-02-7 BRN 0965511 BSPBio_000253 BSPBio_002033 CCRIS 7924 CHEBI:6923 CHEMBL91 CID4189 CPD-4501 Conofite(nitrate) D00416 DB01110 Dactarin Daktarin IV Daktarin iv DivK1c_000156 EINECS 245-324-5 Epi-Monistat(nitrate) Femizol-M Florid(nitrate) Gyno-Daktar(nitrate) HMS1568M15 HMS2090B21 I14-14342 IDI1_000156 Imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl)- (9CI) KBio1_000156 KBio2_001445 KBio2_004013 KBio2_006581 KBio3_001533 KBioGR_000581 KBioSS_001445 LS-78378 Lotrimin AF(nitrate) MCZ MJR 1762 MLS002222203 Micantin (nitrate) Miconasil Nitrate | Miconazol Miconazol [INN-Spanish] Miconazole Miconazole (JP15/USP/INN) Miconazole 3 Miconazole 3 Combination Pack Miconazole 7 Combination Pack Miconazole [USAN:BAN:INN:JAN] Miconazole nitrate salt Miconazole-7 Miconazolo Miconazolo [DCIT] Miconazolum Miconazolum [INN-Latin] Micozole Minostate MolPort-002-557-553 Monazole 7 Monista (nitrate) Monistat Monistat (TN) Monistat 1 Combination Pack Monistat 3 Dual-Pak Monistat 3 Vaginal Ovules Monistat 5 Tampon Monistat 7 Dual-Pak Monistat 7 Vaginal Suppositories Monistat Dual- PAK Monistat IV Monistat iv (TN) Monistat iv (tn) Monistat-Derm NCI60_001353 NCI60_001380 NINDS_000156 NSC 170986 NSC169434 NSC170986 Novo-Miconazole Vaginal Ovules Oprea1_091955 Prestwick0_000067 Prestwick1_000067 Prestwick2_000067 Prestwick3_000067 Prestwick_335 R 18134 R-14,889 SMR001307249 SPBio_000976 SPBio_002174 STK834405 STOCK1S-93556 Spectrum2_001048 Spectrum3_000507 Spectrum4_000061 Spectrum5_001297 Spectrum_000965 UNII-7NNO0D7S5M Vusion Zimycan imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl) methoxy)ethyl)- (9CI) miconazole | |
| | 31 | | rituximab | approved | Phase 4, Phase 3, Phase 2, Phase 1, Early Phase 1 | 1692 | 174722-31-7 | 10201696 | AntiCD20 IDEC-102 IDEC-C2B8 | Ig gamma-1 chain C region MabThera Mabthera Rituxan rituximab |
| | 32 | | Bortezomib | approved, investigational | Phase 4, Phase 3, Phase 2, Phase 1, Early Phase 1 | 807 | 179324-69-7 | 387447, 93860 | 179324-69-7 AC1L8TUW Bortezomib Bortezomib (JAN/USAN/INN) CHEBI:287372 CHEBI:41143 CHEMBL325041 CID387447 D03150 DB07475 DPBA FT-0082488 I14-3268 LDP-341 LDP341 LPD 341 LPD-341 | MLN341 MolPort-003-845-298 N-[(1R)-1-(DIHYDROXYBORYL)-3-METHYLBUTYL]-N-(PYRAZIN-2-YLCARBONYL)-L-PHENYLALANINAMIDE N-[(1R)-1-(DIHYDROXYBORYL)-3-methylbutyl]-N-(pyrazin-2-ylcarbonyl)-L-phenylalaninamide N-[(1R)-1-(dihydroxyboranyl)-3-methylbutyl]-Nalpha-(pyrazin-2-ylcarbonyl)-L-phenylalaninamide NCI60_029010 NSC-681239 NSC681239 PROSCRIPT BORONIC ACID PS-341 Pyz-Phe-boroLeu S1013_Selleck SBB071337 Velcade Velcade (TN) Velcade, MG-341, PS-341, Bortezomib [(1R)-3-methyl-1-({(2S)-3-phenyl-2-[(pyrazin-2-ylcarbonyl)amino]propanoyl}amino)butyl]boronic acid [(1R)-3-methyl-1-[[(2S)-3-phenyl-2-(pyrazine-2-carbonylamino)propanoyl]amino]butyl]boronic acid bortezomib |
| | 33 | | Epirubicin | approved | Phase 4, Phase 3, Phase 2, Phase 1 | 394 | 56420-45-2 | 41867 | (1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-(methyloxy)-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranoside (1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranoside (7S,9R)-7-[(2S,4S,5R,6S)-4-Amino-5-hydroxy-6-methyl-oxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione (7S,9S)-7-[(2R,4S,5R,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione 10-((3-amino-2,3,6-trideoxy-beta-L-arabino-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-(8S-cis)-5,12-naphthacenedione 4'-Epi-DXR 4'-Epiadriamycin 4'-Epidoxorubicin 4'-epi-DX 4'-epi-Doxorubicin 4'-epidoxorubicin 4-Epidoxorubicin 56390-09-1 56390-09-1 (hydrochloride) 56420-45-2 57918-25-9 AC1L26NP AC1Q6JIV BRN 1445813 C11230 C27H29NO11 CCRIS 2261 CHEBI:47898 CHEMBL417 CID41867 D07901 DB00445 Ellence Epi-DX Epi-Dx Epiadriamycin Epidoxorubicin Epirubicin | Epirubicin (INN) Epirubicin [INN:BAN] Epirubicina Epirubicina [INN-Spanish] Epirubicina [Spanish] Epirubicine Epirubicine [French] Epirubicine [INN-French] Epirubicinum Epirubicinum [INN-Latin] Epirubicinum [Latin] Farmorubicin (TN) HSDB 6962 IMI 28 LS-187190 LS-93992 MLS000759412 NChemBio.2007.10-comp15 NSC 256942 NSC-256942 NSC256942 Pharmorubicin Pfs Pidorubicin Pidorubicina Pidorubicina [INN-Spanish] Pidorubicine Pidorubicine [INN-French] Pidorubicinum Pidorubicinum [INN-Latin] Ridorubicin SMR000466308 Triferric doxorubicin UNII-3Z8479ZZ5X WP 697 | |
| | 34 | | Sirolimus | approved, investigational | Phase 4, Phase 3, Phase 2, Phase 1, Early Phase 1 | 1940 | 53123-88-9 | 5284616, 6436030, 46835353 | (-)-Rapamycin (-)-rapamycin 1fkb 1pbk 23,27-Epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine 23,27-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine 23,27-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine-1,5,11,28,29 3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone 53123-88-9 A422989, NSC226080 AC-722 AC1L1JH9 AC1L7MJ9 AC1L9ZMV AY 22989 AY-22989 AY22989 Ambotz53123-88-9 Antibiotic AY 22989 BIDD:PXR0165 Bio1_000293 Bio1_000782 Bio1_001271 Bio2_000375 Bio2_000855 BiomolKI2_000084 C07909 C51H79NO13 CBiol_002007 CCRIS 9024 CHEBI:100923 CHEBI:9168 CHEMBL413 CID10213190 CID10795871 CID11949238 CID11959112 CID313006 CID478951 CID5040 CID5284616 CID5358081 CID5374464 CID5460439 CID5497196 CID5924240 CID6436030 CID6610270 CID6610346 CID6711160 CID6713081 CID9833581 CID9854379 CID9854380 CID9962926 CID9962928 D00753 DB00877 DE-109 DivK1c_006936 | FT-0082351 HMS2089A21 HSDB 7284 KBio1_001880 KBio2_000410 KBio2_002978 KBio2_005546 KBio3_000779 KBio3_000780 KBioGR_000410 KBioSS_000410 LCP-Siro LMPK06000003 LS-143290 MLS000028373 MS-R001 MolMap_000043 MolPort-003-959-433 NCGC00021305-05 NCI60_001851 NCIMech_000355 NSC 226080 NSC226080 Perceiva QTL1_000069 R0395_SIAL R0395_SIGMA RAP RAPA RPM Rapammune Rapamune Rapamune (TN) Rapamycin Rapamycin (TN) Rapamycin C-7, analog 4 Rapamycin Immunosuppressant Drug Rapamycin from Streptomyces hygroscopicus S1039_Selleck SIIA 9268A SILA 9268A SILA9268A SMP1_000255 SMR000058564 Sirolimus Sirolimus (RAPAMUNE) Sirolimus (USAN/INN) Sirolimus [USAN:BAN:INN] Sirolimus, Rapamune,Rapamycin SpecPlus_000840 UNII-W36ZG6FT64 UNM-0000358684 WY-090217 Wy 090217 heptadecahydro-9,27-dihydroxy-3-[(1R)-2-[(1S,3R,4R)-4-hydroxy nchembio.100-comp4 nchembio.2007.42-comp2 nchembio.79-comp1 nchembio762-comp1 nchembio883-comp3 rapamycin sirolimus |
| | 35 | | Cytarabine | approved, investigational | Phase 4, Phase 3, Phase 2, Phase 1, Early Phase 1 | 1117 | 147-94-4 | 6253 | (beta-D-Arabinofuranosyl)cytosine (beta-D-arabinofuranosyl)cytosine 1-.beta.-D-arabinofuranosyl-cytosine 1-Arabinofuranosylcytosine 1-beta -D-Arabinofaranosylcytosine 1-beta -D-Arabinofuranosyl-4-amino-2(1H)pyrimidinone 1-beta -D-Arabinofuranosylcytosine 1-beta-D-Arabinofaranosylcytosine 1-beta-D-Arabinofuranosyl-4-amino-2(1H)pyrimidinone 1-beta-D-Arabinofuranosyl-Cytosine 1-beta-D-Arabinofuranosylcytosine 1-beta-D-Arabinofuranosylcytosine, Cytosine Arabinoside 1-beta-D-Arabinosyl-Cytosine 1-beta-D-Arabinosylcytosine 147-94-4 1beta -Arabinofuranasylcytosine 1beta -D-Arabinofuranosylcytosine 1beta -D-Arabinosylcytosine 1beta-Arabinofuranasylcytosine 1beta-D-Arabinofuranosylcytosine 1beta-D-Arabinosylcytosine 2(1H)-Pyrimidinone, 4-amino-1- -D-arabinofuranosyl- [CAS] 2(1H)-Pyrimidinone, 4-amino-1- -D-arabinofuranosyl 30399_FLUKA 4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidin 4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidin [Czech] 4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidine 4-Amino-1-b-D-arabinofuranosyl-2-(1H)-pyrimidinone 4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinon 4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinon [Czech] 4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinone 4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one 4-amino-1-beta-D-arabinofuranosylpyrimidin-2(1H)-one 69-74-9 (hydrochloride) AC-1075 AC1L1M4F AC1Q52OJ AI3-52329 AR3 Alexan Ara-C Ara-C, Cytosine Arabinoside, Cytosar-U, Cytarabine Ara-Cytidine AraC Arabinocytidine Arabinofuranosylcytosine Arabinosyl Cytosine Arabinosylcytosine Arabitin Aracytidine Aracytin Aracytine Arafcyt BIDD:GT0371 BIDD:PXR0139 BTB15125 Beta-cytosine arabinoside C02961 C1768_SIGMA C2035 C9H13N3O5 CCRIS 913 CHEBI:28680 CHEMBL803 CHX 3311 CID6253 CPD000449317 CYTARABINE (SEE ALSO CYTARABINE HYDROCHLORIDE 69-74-9) Citarabina Citarabina [INN-Spanish] Cytarabin Cytarabina Cytarabine (JP15/USP/INN) Cytarabine [USAN:INN:BAN:JAN] | Cytarabine liposome injection Cytarabinoside Cytarabinum Cytarabinum [INN-Latin] Cytarbel Cytonal Cytosar Cytosar-U Cytosine 1-beta-D-arabinofuranoside Cytosine arabinofuranoside Cytosine arabinose Cytosine arabinoside Cytosine arabinoside (VAN) Cytosine beta-D-arabinofuranoside Cytosine beta-D-arabinofuranoside hydrochloride Cytosine beta-D-arabinoside Cytosine, beta -D-arabinoside Cytosine, beta-D-arabinoside Cytosine-1-beta-D-arabinofuranoside Cytosine-1-beta-D-arabinofuranoside hydrochloride Cytosine-beta -D-arabinofuranoside Cytosine-beta -arabinoside Cytosine-beta-D-arabinofuranoside Cytosine-beta-arabinoside Cytosinearabinoside D00168 DB00987 DepoCyte Depocyt Depocyt (TN) Depocyt (liposomal) Depocyte EINECS 205-705-9 Erpalfa FT-0082880 HMS2051K19 HMS2090A18 HSDB 3049 Intrathecal (injected into the spinal fluid) DepoCyt Intrathecal cytarabine (also known as ara-C) Iretin LS-860 Lopac0_000316 MLS000758310 MLS001066340 MolPort-001-792-509 NCGC00093356-03 NCGC00093356-04 NCGC00093356-05 NCI-C04728 NSC 287459 NSC287459 S1648_Selleck SAM001247012 SMR000449317 SR-01000075773-3 Spongocytidine TL8001048 Tarabine U 19920A U-19,920 U-19920 UNII-04079A1RDZ Udicil ZINC03795098 beta -D-arabinosylcytosine beta -arabinosylcytosine beta -cytosine arabinoside beta-Ara C beta-Ara c beta-Arabinosylcytosine beta-Cytosine arabinoside beta-D-Arabinosylcytosine cytarabine cytarabine liposome injection cytosine-β-D-arabinofuranoside |
| | 36 | | Mesna | approved | Phase 4, Phase 3, Phase 2, Phase 1 | 263 | 3375-50-6 | 598 | 2-Mercaptoethane 2-Mercaptoethanesulfonate 2-Mercaptoethanesulfonic acid 2-mercaptoethanesulfonic acid 2-mercaptoethanesulphonic acid 2-mercaptoethylsulfonate 2-sulfanylethylsulfonate | CoM Coenzima M Coenzym M Coenzyme M HS-CoM reduced CoM reduced coenzyme M β-mercaptoethanesulfonic acid | |
| | 37 | | Lenalidomide | approved | Phase 4, Phase 3, Phase 2, Phase 1, Early Phase 1 | 736 | 191732-72-6 | 216326 | 1-oxo-2-(2,6-Dioxopiperidin-3-yl)-4-aminoisoindoline 191732-72-6 3-(4-Amino-1-oxo-1,3-dihydro-2H-isoindol-2-yl)piperidine-2,6-dione 3-(4-Amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione 3-(7-Amino-3-oxo-1H-isoindol-2-yl)-piperidine-2,6-dione 3-(7-amino-3-oxo-1H-isoindol-2-yl)piperidine-2,6-dione 346670-73-3 443912-14-9 AC-914 AC1L50II AKOS005146276 ALBB-015321 Bio-0168 C467567 CC 5013 CC-5013 CC-5013, Revlimid, Lenalidomide CC5013 CDC 501 CDC-501 CDC-5013 CHEMBL848 CID216326 Celgene brand of lenalidomide D04687 | DB00480 EC-000.2340 ENMD-0997 I06-0831 IMID-1 IMID-5013 IMiD3 IMiD3 cpd IMid-1 LS-184040 Lenalidomide Lenalidomide (USAN/INN) Lenalidomide [USAN] MolPort-003-848-370 NCGC00167491-01 NSC747972 Revamid Revimid Revlimid Revlimid (Celgene) Revlimid (TN) S1029_Selleck STK639603 Thalidomide analog CC-5013 UNII-F0P408N6V4 lenalidomide | |
| | 38 | | Rifampin | approved | Phase 4, Phase 1 | 348 | 13292-46-1 | 5458213, 5381226 | 1-b]furan-21-yl acetate 13292-46-1 3-(((4-Methyl-1-piperazinyl)imino)-methyl)rifamycin 3-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV 3-(4-Methylpiperazinyliminomethyl)-rifamycin SV 3-(4-Methylpiperazinyliminomethyl)rifamycin SV 3-([(4-Methyl-1-piperazinyl)imino]methyl)rifamycin SV 3-[(4-Methyl-1-piperazinyl)iminomethyl]rifamycin SV 3-[[(4-Methyl-1-piperazinyl)imino]-methyl]rifamycin 46713_FLUKA 46713_RIEDEL 62534-43-4 8-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV 8-(4-Methylpiperazinyliminomethyl) rifamycin SV 8-[[(4-Methyl-1-piperazinyl)imino[methyl]rifamycin 8-[[(4-Methyl-1-piperazinyl)imino]methyl]rifamycin sv 8-[[(4-Methylpiperazinyl)imino]methyl]rifamycin sv 83907_FLUKA 83907_SIGMA 8CI) AZT + Rifampin Abrifam Archidyn Arficin Arzide BA-41166E BIDD:PXR0014 BPBio1_000561 BSPBio_000509 Ba 41166 Ba 41166/E Benemicin Benemycin Bio-0621 C06688 C43H58N4O12 CAS-13292-46-1 CCRIS 551 CHEBI:28077 CHEBI:455936 CHEMBL180 CID5381226 CID5388984 CID5458213 CID5702112 CID6604339 CID6708473 CID6842115 CID6912767 CID6913622 CPD001906767 D00211 DB01045 DRG-0109 Dione 21-acetate Dipicin DivK1c_000550 Doloresum EINECS 236-312-0 Eremfat Famcin Fenampicin HMS1569J11 HMS1920P08 HMS2089F12 HMS2092G09 HMS501L12 HSDB 3181 KBio1_000550 KBio2_000919 KBio2_003487 KBio2_006055 KBio3_003018 KBioGR_001780 KBioSS_000919 L-5103 L-5103 Lepetit LS-7689 MLS000028552 MLS001148237 MLS001333745 MolPort-000-767-051 MolPort-002-513-586 MolPort-003-666-281 MolPort-006-395-891 NCGC00016699-01 NCGC00017365-01 NCGC00018178-01 NCGC00022678-03 NCGC00022678-04 NCGC00022678-05 NCGC00160500-01 | NCI60_000309 NINDS_000550 NSC 113926 NSC-113926 NSC113926 Piperine & Rifampicin Prestwick0_000525 Prestwick1_000525 Prestwick2_000525 Prestwick3_000525 Prestwick_833 R-Cin R/AMP R0079 R3501_SIAL R3501_SIGMA R5777_SIGMA R7382_SIGMA RAMP RFP RMP Ramp Reserpine & Rifampicin Rf Rfamipicin Rifa Rifadin Rifadin (TN) Rifadin I.V Rifadin I.V. Rifadin IV Rifadin Iv Rifadin, Rimactane, Rifampicin, Rifampin Rifadine Rifagen Rifaldazin Rifaldazine Rifaldin Rifam Rifamicin AMP Rifamor Rifampicin Rifampicin & EEP Rifampicin & Propolis Rifampicin (JP15/INN) Rifampicin SV Rifampicin [INN:BAN:JAN] Rifampicina Rifampicina [INN-Spanish] Rifampicine Rifampicine [French] Rifampicinum Rifampicinum [INN-Latin] Rifampin Rifampin (USP) Rifampin [USAN] Rifamsolin Rifamycin Rifamycin AMP Rifamycin Amp Rifaprodin Rifcin Rifinah Rifobac Rifoldin Rifoldine Riforal Rimactan Rimactane Rimactane (TN) Rimactazid Rimactin Rimactizid Rimazid Rimycin Rofact S1764_Selleck SAM002264646 SMR000058322 SMR000653525 SPBio_002430 SPECTRUM1500529 STK080143 Sinerdol Spectrum3_001837 Spectrum4_001250 Spectrum5_002018 Spectrum_000439 TNP00313 Tubocin UNII-VJT6J7R4TR WLN: V1 WQ A&1 E&1 E1UN- AT6N DNTJ D1 nchembio884-comp4 rifampin |
| | 39 | | Vancomycin | approved | Phase 4, Phase 3 | 332 | 1404-90-6 | 441141, 14969 | (1S,2R,18R,22S,25R,28R,40S)-22-(2-amino-2-Oxoethyl)-48-[2-O-(3-amino-2,3,6-trideoxy-3-methyl-alpha-L-lyxo-hexopyranosyl)-beta-D-glucopyranosyloxy]-5,15-dichloro-2,18,32,35,37-pentahydroxy-19-[(N-methyl-D-leucyl)amino]-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentaazaoctacyclo[26.14.2.2(3,6).2(14,17).1(8,12).1(29,33).0(10,25).0(34,39)]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34,36,38,46,49-pentadecaene-40-carboxylic acid (2.2Sp,3.5sa,2.6sp)-O(4.2),C(3.4):c(5.4),O(4.6):c(3.5),C(2.7)-tricyclo[N-methyl-D-leucyl-3-chloro-(R)-beta-hydroxy-D-tyrosyl-L-asparaginyl-D-2-(4-{[2-O-(3-amino-2,3,6-trideoxy-3-C-methyl-alpha-L-lyxo-hexopyranosyl)-beta-D-glucopyranosyl]oxy}phenyl)glycyl-D-2-(4-hydroxyphenyl)glycyl-3-chloro-(R)-beta-hydroxy-L-tyrosyl-L-2-(3,5-dihydroxyphenyl)glycine] 1404-90-6 1404-93-9 (hydrochloride) 64685-75-2 (sulfate) AC1L24VU AC1L9AMI AC1Q29OH BIDD:GT0353 C06689 C66H75Cl2N9O24 CHEBI:28001 CHEMBL262777 CID14969 CID441141 CID5311496 CID6426898 CID6917992 D00212 DB00512 EINECS 215-772-6 HSDB 3262 LMPK14000004 | LS-161387 Lopac0_001267 MolPort-001-794-649 NCGC00162383-02 Prestwick0_000497 Prestwick1_000497 Prestwick2_000497 SPBio_002314 UNII-6Q205EH1VU VAN VANCOMYCIN Vancocin Vancocin (TN) Vancocin HCL Vancomicina Vancomicina [INN-Spanish] Vancomycin Vancomycin (USP) Vancomycin HCL Vancomycin [USAN:INN:BAN] Vancomycine Vancomycine [INN-French] Vancomycinum Vancomycinum [INN-Latin] nchembio.350-comp1 |
| | 40 | | Lenograstim | approved | Phase 4, Phase 3, Phase 2, Phase 1, Early Phase 1 | 1220 | 135968-09-1 | | G-CSF (CHO cell derived) Glycosylated recombinant G-CSF Glycosylated recombinant granulocyte colony stimulating factor | Granulocyte colony stimulating factor 3 (CHO cell derived) Granulocyte colony-stimulating factor lenograstim Lenograstim (genetical recombination) Lenograstim rDNA | |
| | 41 | | Panobinostat | approved, investigational | Phase 4, Phase 3, Phase 1, Phase 2 | 135 | 404950-80-7 | 6918837 | (2E)-N-hydroxy-3-[4-({[2-(2-methyl-1H-indol-3-yl)ethyl]amino}methyl)phenyl]acrylamide (E)-N-HYDROXY-3-(4-{[2-(2-METHYL-1H-INDOL-3-YL)-ETHYLAMINO]-METHYL}-PHENYL)-ACRYLAMIDE (E)-N-hydroxy-3-[4-[[2-(2-methyl-1H-indol-3-yl)ethylamino]methyl]phenyl]prop-2-enamide 404950-80-7 AC1OCFY8 AKOS005146046 C496932 CHEMBL483254 CID6918837 EC-000.2287 FT-0083488 Faridak | LBH 589 LBH-589 LBH-589B LBH589 MolPort-005-933-338 NVP-LBH-589 NVP-LBH589 Panobinostat Panobinostat, NVP-LBH589, LBH589 S1030_Selleck ZINC22010649 nchembio.313-comp11 panobinostat | |
| | 42 | | Melphalan | approved | Phase 4, Phase 3, Phase 2, Phase 1, Early Phase 1 | 729 | 148-82-3 | 4053, 460612 | (2S)-2-amino-3-[4-[bis(2-chloroethyl)amino]phenyl]propanoic acid (2s)-2-amino-3-(4-[bis(2-chloroethyl)amino]phenyl)propanoic acid 148-82-3 3-(P-(Bis(2-chloroethyl)amino)phenyl)-L-alanine 3-(p-(Bis(2-chloroethyl)amino)phenyl)-L-alanine 3-(p-(Bis(2-chloroethyl)amino)phenyl)alanine 3-P-(Di(2-chloroethyl)amino)-phenyl-L-alanine 3-p-(Di(2-chloroethyl)amino)-phenyl-L-alanine 3025 C.B. 3025 c.b 3223-07-2 4-(Bis(2-chloroethyl)amino)-L-phenylalanine 4-14-00-01689 (Beilstein Handbook Reference) 4-[Bis(2-chloroethyl)amino]-L-phenylalanine 4-[Bis-(2-chloroethyl)amino]-L-phenylalanine AC1LA2OE ALKERAN (TN) AY3360000 Alanine Nitrogen Mustard Alkeran AmbotzHAA1563 At-290 BIDD:GT0044 BRD-K87827419-001-02-8 BRN 2816456 BSPBio_002407 C13H18Cl2N2O2 CB 3025 CB-3025 CCRIS 374 CHEBI:165415 CHEBI:28876 CHEMBL852 CID460612 D00369 DivK1c_000653 EINECS 205-726-3 HMS2090B09 HMS2091B16 HMS502A15 HSDB 3234 IDI1_000653 KBio1_000653 KBio2_000877 KBio2_003445 KBio2_006013 KBio3_001627 KBioGR_001284 KBioSS_000877 L-3-(P-(Bis(2-chloroethyl)amino)phenyl)alanine L-3-(p-(Bis(2-chloroethyl)amino)phenyl)alanine L-3-(para-(Bis(2-chloroethyl)amino)phenyl)alanine L-PAM L-Phenylalanine mustard L-Sarcolysin L-Sarcolysine L-Sarkolysin LS-15868 LS-865 | Levofalan Levofolan Levopholan M2011_SIGMA MELPHALAN (SEE ALSO TRANSGENIC MODEL EVALUATION (MELPHALAN)) MLS001333666 MLS002153368 Melfalan Melfalano Melfalano [INN-Spanish] Melphalan (JP15/USP/INN) Melphalan [USAN:INN:BAN:JAN] Melphalanum Melphalanum [INN-Latin] Mephalan MolPort-003-665-535 NCGC00090757-01 NCGC00090757-02 NCGC00090757-03 NCI-C04853 NINDS_000653 NIOSH/AY3360000 NSC 241286 NSC 8806 NSC-8806 NSC241286 NSC8806 P-Di-(2-chloroethyl)amino-L-phenylalanine P-L-Sarcolysin P-N-Bis(2-chloroethyl)amino-L-phenylalanine Phenylalanine mustard Phenylalanine nitrogen mustard Prestwick_1006 RCRA waste no. U150 Rcra waste number U150 SK-15673 SMP2_000174 SMR000058720 SPBio_000287 SPECTRUM1500382 Sarcolysine Sarkolysin Spectrum2_000074 Spectrum3_000684 Spectrum4_000882 Spectrum5_001601 Spectrum_000397 TL8001065 TRANSGENIC LEP (MELPHALAN) (SEE ALSO MELPHALAN) TRANSGENIC MODEL EVALUATION (MELPHALAN) UNII-Q41OR9510P melphalan p-Bis(beta-chloroethyl)aminophenylalanine p-Di-(2-chloroethyl)amino-L-phenylalanine p-L-Sarcolysin p-L-sarcolysine p-N,N-bis(2-chloroethyl)amino-L-phenylalanine p-N-Bis(2-chloroethyl)amino-L-phenylalanine p-N-Di(chloroethyl)aminophenylalanine p-N-di(chloroethyl)aminophenylala nine phenylalanine nitrogen mu stard |
| | 43 | | Phentolamine | approved | Phase 4 | 22 | 50-60-2 | 5775 | 2-((N-(m-Hydroxyphenyl)-p-toluidino)methyl)-2-imidazoline 2-(N'-p-Tolyl-N'-m-hydroxyphenylaminomethyl)-2-imidazoline 2-(N-(m-Hydroxyphenyl)-P-toluidinomethyl)imidazoline 2-(N-(m-Hydroxyphenyl)-p-toluidinomethyl)imidazoline 2-(m-Hydroxy-N-p-tolylanilinomethyl)-2-imidazoline 3-[(4,5-dihydro-1H-imidazol-2-ylmethyl)(4-methylphenyl)amino]phenol 3-[N-(4,5-dihydro-1H-imidazol-2-ylmethyl)-4-methylanilino]phenol 5-25-09-00365 (Beilstein Handbook Reference) 50-60-2 65-28-1 (mesylate (salt)) 73-05-2 (mono-hydrochloride) AC1L1L3Z AC1Q2KIW AKOS004119917 BCBcMAP01_000014 BPBio1_000307 BRD-K90333595-001-02-8 BRD-K90333595-003-04-0 BRN 0272944 BSPBio_000279 BSPBio_001435 BSPBio_002496 C 7337 C 7337 Ciba C17H19N3O CAS-73-05-2 CHEBI:120131 CHEMBL597 CID5775 D08362 DB00692 Dibasin DivK1c_000807 EINECS 200-053-1 Fentolamin Fentolamina Fentolamina [INN-Spanish] HMS1791H17 HMS1989H17 HMS2089E03 HSDB 3382 IDI1_000807 KBio1_000807 KBio2_000477 KBio2_003045 KBio2_005613 KBio3_001716 KBioGR_001338 KBioSS_000477 | L001116 LS-104396 Lopac0_000982 MLS000040874 MLS001201741 MolPort-001-783-569 NCGC00016311-01 NCGC00016311-02 NCGC00016311-03 NCGC00016311-15 NCGC00021804-06 NCGC00021804-07 NCGC00021804-08 NCGC00021804-09 NCGC00021804-10 NINDS_000807 Phenotolamine Phentalamine Phentolamin Phentolamine Phentolamine (INN) Phentolamine [INN:BAN] Phentolamine mesylate Phentolamine mesylate [USAN] Phentolamine methanesulfonate Phentolamine, methyl sulfonate Phentolaminum Phentolaminum [INN-Latin] Prestwick0_000230 Prestwick1_000230 Prestwick2_000230 Prestwick3_000230 Regitin Regitina Regitine Regitipe Regityn Rogitine SMP1_000236 SMR000058051 SPBio_002200 STK802099 STOCK4S-00358 Spectrum3_000788 Spectrum4_000899 Spectrum5_001704 Spectrum_000077 UNII-Z468598HBV Vesomax nchembio705-6 phentolamine |
| | 44 | | Budesonide | approved | Phase 4, Phase 1 | 432 | 51333-22-3 | 63006, 5281004 | (11-beta,16-alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione (11beta,16alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione (4aR,4bS,5S,6aS,6bS,8R,9aR,10aS,10bS)-5-hydroxy-6b-(hydroxyacetyl)-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one (4aR,4bS,5S,6aS,6bS,9aR,10aS,10bS)-5-hydroxy-6b-(hydroxyacetyl)-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one (R,S)-11b,16a,17,21,tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with buty raldehyde (RS)-(11beta,16alpha)-16,17-[Butylidenebis(oxy)]-11,21-dihydroxypregna-1,4-diene-3,20-dione (RS)-11beta,16alpha,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with butyraldehyde (S)-16alpha,17-(Butylidenedioxy)-11beta,21-dihydroxypregna-1,4-diene-3,20-dione 11beta,21-dihydroxy-16alpha,17alpha-(butane-1,1-diyldioxy)pregna-1,4-diene-3,20-dione 16,17-Butylidenebis(oxy)-11,21-dihydroxypregna-1,4-diene-3,20-dione 16,17-Butylidenebis(oxy)-11-,21-dihydroxypregna-1,4-diene-3,20-dione 16-alpha,17-alpha-Butylidenedioxy-11-beta,21-dihydroxy-1,4-pregnadiene-3,20-dione 16alpha(R),17-(Butylidenebis(oxy))-11beta,21-dihydroxypregna-1,4-diene-3,20-dione 16alpha-,17alpha--butylidenedioxypregna-1,4-diene-11beta-,21-diol-3,20-dione 51333-22-3 AC-4697 AC1L1DQE AC1L1Y6Y AC1L22VC AC1MHWI7 B 7777 B7777_SIGMA BPBio1_000523 BRD-A34299591-001-03-4 BRD-A82238138-001-01-7 BSPBio_000475 BSPBio_002160 Bidien Bio-0010 Budecort Inhaler Budenofalk Budeson Budesonide (JAN/USAN/INN) Budesonide Easyhaler Budesonide MMX Budesonide [USAN:INN:BAN:JAN] Budesonido Budesonido [INN-Spanish] Budesonidum Budesonidum [INN-Latin] Budiair Budicort C25H34O6 CCRIS 5230 CHEBI:3207 CHEBI:656601 CHEMBL1370 CID2462 CID3033890 CID40000 CID5281004 CID63006 CPD000058337 Cortivent D00246 DB01222 Desowen Dexbudesonide Dexbudesonide [INN] DivK1c_000475 EINECS 257-139-7 EINECS 257-160-1 EINECS 257-161-7 EU-0100174 Entocort Entocort EC Entocort EC (TN) Giona Easyhaler HMS1569H17 HMS1921I22 HMS2094I13 HMS501H17 Horacort | IDI1_000475 Inflammide KBio1_000475 KBio3_001660 KBioGR_001361 LS-187734 LS-7235 Lopac0_000174 MAP-0010 MLS000028507 MLS001077323 MLS002207112 Micronyl Miflonide MolPort-002-529-265 MolPort-003-666-332 MolPort-003-986-909 NCGC00015165-03 NCGC00021318-03 NCGC00021318-06 NCGC00089747-02 NCGC00089747-03 NCGC00089747-04 NCGC00178789-01 NINDS_000475 Noex Preferid Pregna-1,4-diene-3,20-dione, 16,17-butylidenebis(oxy)-11,21-dihydroxy-, (11beta,16alpha(R))-, and 16alpha,17-((S)-Butylidenebis(oxy))-11beta,21-dihydroxypregna-1,4-diene-3,20-dione Prestwick0_000518 Prestwick1_000518 Prestwick2_000518 Prestwick3_000518 Prestwick_840 Pulmaxan Pulmaxan turbohaler Pulmicort Pulmicort (TN) Pulmicort Flexhaler Pulmicort Nebuamp Pulmicort Respules Pulmicort Topinasal Pulmicort Turbuhaler Pulmicort turbuhaler Respules Rhinocort Rhinocort Aqua Rhinocort Turbuhaler Rhinocort alpha Rhinocort, Pulmicort , Entocort, Symbicort, Noex. Entocort EC, Budesonide Rhinosol S 1320 S-1320 S1286_Selleck SAM002699898 SMR000058337 SPBio_000586 SPBio_002396 SPECTRUM1500813 ST51039033 Spectrum2_000623 Spectrum3_000620 Spectrum4_000821 Spectrum5_001738 Spirocort TL8003397 Tridesilon UDB UNII-168L5HT37P UNII-2HI1006KPH UNII-Q3OKS62Q6X Unit dose budesonide ZINC03938751 ZINC04097286 budesonide | |
| | 45 | | Piperacillin | approved | Phase 4, Phase 3 | 101 | 66258-76-2 | 43672 | (2S,5R,6R)-6-[[(2R)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid (2S,5R,6R)-6-{[(2R)-2-{[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino}-2-phenylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid (2S-(2alpha,5alpha,6beta(S*)))-6-(((((4-Ethyl-2,3-dioxopiperazin-1-yl)carbonyl)amino)phenylacetyl)amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid 4-ethyl-2,3-dioxopiperazine carbonyl ampicillin 59703-84-3 59703-84-3 (mono-hydrochloride salt) 6-(D-(-)-alpha-(4-Ethyl-2,3-dioxo-1-piperazinecarboxamido)phenylacetamido)penicillanic acid 61477-96-1 6beta-{(2R)-2-[(4-ethyl-2,3-dioxopiperazin-1-yl)carboxamido]-2-phenylacetamido}-2,2-dimethylpenam-3alpha-carboxylic acid AC1L2ACR AC1Q5QXJ BIDD:GT0167 BPBio1_000848 BRD-K86873305-236-03-0 BSPBio_000770 C14034 C23H27N5O7S CCRIS 7362 CHEBI:8232 CHEMBL702 CID43672 Cl-227193 D08380 EINECS 262-811-8 HMS2090H19 LS-149794 | PIPC PIPERACILLIN SODIUM Peperacillin Peracin Peracin (TN) Piperacilina Piperacillin Piperacillin (INN) Piperacillin (anhydrous) Piperacillin Anhydrous Piperacillin Monosodium Salt Piperacillin anhydrous Piperacillina Piperacillinum Pipercillin Pipracil Pipracil, Piper Pipril Pipéracilline Prestwick0_000755 Prestwick1_000755 Prestwick2_000755 Prestwick3_000755 SPBio_002709 T-1220 UNII-9I628532GX piperacillin | |
| | 46 | | Azacitidine | approved, investigational | Phase 4, Phase 3, Phase 2, Phase 1 | 529 | 320-67-2 | 9444 | 2-(beta-D-Ribofuranosyl)-4-amino-1,3,5-triazin-2-one 320-67-2 4-Amino-1-(beta-D-ribofuranosyl)-1,3,5-triazin-2(1H)-one 4-Amino-1-beta-D-ribofuranosyl-1,3,5-traizin-2(1H)-one 4-Amino-1-beta-D-ribofuranosyl-1,3,5-triazine-2(1H)-one 4-Amino-1-beta-D-ribofuranosyl-S-triazin-2(1H)-one 4-Amino-1-beta-D-ribofuranosyl-s-triazin-2(1H)-one 4-Amino-1-beta-d-ribofuranosyl-1,3,5-triazin-2(1H)-one 4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3,5-triaz 4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3,5-triazin-2-one 4-amino-1-beta-L-ribofuranosyl-1,3,5-triazin-2(1H)-one 5 AZC 5 Azacytidine 5-AC 5-AZAC 5-AZCR 5-Azacytidine 5-aza-CR 5-azacitidine 5-azacytidine 5-azacytidine, Mylosar, Ladakamycin, Vidaza, Azacitidine 5AzaC A 2385 A1287_SIGMA A2385_SIGMA AC1L1T1Y Antibiotic U 18496 Azacitidina Azacitidina [INN-Spanish] Azacitidine Azacitidine (JAN/USAN/INN) Azacitidine [USAN:INN] Azacitidinum Azacitidinum [INN-Latin] Azacytidine BCBcMAP01_000083 BRN 0620461 BSPBio_003157 C11262 CCRIS 60 CHEBI:2038 CHEMBL1489 CID9444 CPD000857239 D001374 D03021 DB00928 DivK1c_000125 EINECS 206-280-2 EU-0100035 FT-0081170 HMS1921J22 HMS2092D08 HMS500G07 HSDB 6879 IDI1_000125 InChI=1/C8H12N4O5/c9-7-10-2-12(8(16)11-7)6-5(15)4(14)3(1-13)17-6/h2-6,13-15H,1H2,(H2,9,11,16)/t3-,4-,5-,6-/m1/s1 | Jsp005945 KBio1_000125 KBio2_001742 KBio2_002556 KBio2_004310 KBio2_005124 KBio2_006878 KBio2_007692 KBio3_002657 KBio3_003034 KBioGR_001444 KBioGR_002556 KBioSS_001742 KBioSS_002565 LS-1189 Ladakamycin Lopac0_000035 MLS001333121 MLS001333122 MLS002153249 MolMap_000062 Mylosar NCGC00090851-01 NCGC00090851-02 NCGC00090851-03 NCGC00090851-04 NCGC00090851-08 NCGC00178234-01 NCI-C01569 NINDS_000125 NS-17 NSC 102816 NSC-102816 NSC102816 Pharmion Brand of Azacitidine S1782_Selleck SAM002264595 SMR000857239 SPBio_000892 SPECTRUM1502111 ST056940 Spectrum2_000786 Spectrum3_001509 Spectrum4_000922 Spectrum5_001166 Spectrum_001262 TL80073599 U 18496 U-18496 UNII-M801H13NRU Vidaza Vidaza (TN) WR-183027 ZINC03861768 cMAP_000082 mylo sar pyrimidine antimetabolite: inhibits nucleic acid replication s-Triazin-2(1H)-one, 4-amino-1-beta-D-ribofuranosyl- (8CI) wr 183027 |
| | 47 | | Theophylline | approved | Phase 4 | 64 | 58-55-9 | 2153 | 1,3 Dimethylxanthine 1,3-Dimethylxanthine 1,3-dimethyl-7H-purine-2,6-dione 1,3-dimethylxanthine 111079-49-3 1H-purine-2,6-dione 2a3a 46157-00-0 56645-32-0 58-55-9 75448-53-2 AB00052106 AC-20328 AC1L1D1F AI3-50216 AKOS000120961 Accurbron Acet-theocin Aerobin Aerolate Aerolate III Aerolate SR Afonilm Afonilum Afonilum Retard Aminophylline Aquaphyllin Armophylline Asbron Asmalix Asmax Austyn BCBcMAP01_000071 BIDD:ER0557 BIDD:GT0151 BPBio1_000791 BPBio1_001041 BSPBio_000719 BSPBio_000945 BSPBio_002363 Bilordyl Bronchodid Duracap Bronchoparat Bronchoretard Bronkodyl Bronkodyl SR Bronkotabs C07130 C7H8N4O2 CCRIS 4729 CHEBI:28177 CHEMBL190 CID2153 CPD-12479 CPD000058537 Cetraphylline Choledyl SA Chronophyllin Constant T Constant-T ConstantT D00371 D013806 DB00277 Diffumal Dimethylxanthine Diphyllin DivK1c_000203 Doraphyllin Duraphyl Duraphyllin Dyspne-Inhal EINECS 200-385-7 Egifilin Elixex Elixicon Elixomin Elixophyllin Elixophyllin (TN) Elixophyllin SR Elixophyllin(e) Elixophylline Etheophyl Euphylline Euphylong GS 2591A HMS1921E03 HMS2089A06 HMS2092M05 HMS500K05 HSDB 3399 Hylate IDI1_000203 KBio1_000203 KBio2_001518 KBio2_004086 KBio2_006654 KBio3_001583 KBioGR_000785 KBioSS_001518 L000595 LASMA LS-241 LaBID Labid Labophylline Lanophyllin Liquophylline Liquorice Lopac0_000014 MLS000069390 MLS002152943 MLS002153487 Maphylline Medaphyllin MolPort-001-002-058 MolPort-001-737-342 Mudrane NCGC00018117-01 NCGC00018117-16 NCGC00022112-03 NCGC00022112-04 NCGC00022112-05 NCGC00022112-07 NCGC00022112-08 NCGC00022112-09 NCGC00022112-10 NCGC00022112-11 NCI60_001736 NINDS_000203 NSC 2066 NSC2066 Nuelin Nuelin S.A Nuelin S.A. Nuelin SA Optiphyllin PDSP1_001018 PDSP1_001234 PDSP2_001002 PDSP2_001218 Parkophyllin Physpan Prestwick0_000820 Prestwick0_000873 Prestwick1_000820 Prestwick1_000873 Prestwick2_000820 Prestwick2_000873 Prestwick3_000820 Prestwick3_000873 Pro-vent Pseudotheophylline | Pulmidur Pulmo-Timelets Quibron Quibron T Quibron T SR Quibron T-SR Quibron T/SR Quibron TSR Quibron-T Quibron-T/SR Quibron-T/Sr Quibron-t (TN) Respbid Respicur Respid S1621_Selleck SAM002554935 SMP1_000291 SMR000058537 SPBio_000823 SPBio_002640 SPBio_002866 SPECTRUM1500568 ST024762 STK397040 Slo Phyllin Slo-Bid Slo-Phyllin Slo-bid Slo-phyllin SloPhyllin Solosin Somophyllin CRT Somophyllin T Somophyllin-CRT Somophyllin-Crt Somophyllin-DF Somophyllin-T Somophyllin-t SomophyllinT Spectrum2_000842 Spectrum3_000672 Spectrum4_000353 Spectrum5_001232 Spectrum_001038 Spophyllin retard Sustaire Synophylate Synophylate-L.A. Cenules T-Phyl T0179 T1633_SIGMA T4924_SIGMA T7770_SIGMA T9031_SIGMA THEOBID JR Talotren Tefamin Telb-DS Telbans Dry Syrup Teocen 200 Teofilina Teofilina [Polish] Teofyllamin Teolair Teonova Teosona Tesona Theacitin Theal tabl. Theal tablets Theo 24 Theo Dur Theo-11 Theo-24 Theo-24 (TN) Theo-DS Theo-Dur Theo-Dur-Sprinkle Theo-Nite Theo-Organidin Theo-Sav Theo-dur Theo24 Theobid Theobid Duracap Theobid Jr. Theochron Theocin Theoclair-SR Theoclear Theoclear 80 Theoclear L.A.-130 Theoclear LA Theoclear-200 Theoclear-80 Theocontin Theodel Theodrip Theodur Theodur Dry Syrup Theodur G Theodur G (TN) Theofol Theograd Theokin Theolair Theolair (TN) Theolair-SR Theolair-Sr Theolix Theolixir Theona P Theonite Theopek Theophyl Theophyl-225 Theophyl-SR Theophyl-Sr Theophyline Theophyllin Theophylline (JP15) Theophylline anhydrous Theophylline, anhydrous Theophylline-SR Theophylline-Sr Theophylline-[8-3H Theoplus Theospan Theostat Theostat 80 Theotard Theovent UNII-0I55128JYK UPCMLD-DP123 UPCMLD-DP123:001 Uni-Dur Unifyl Unilong Uniphyl Uniphyl (TN) Uniphyllin Uniphyllin continus Uniphylline X 115 Xanthium Xantivent ZINC18043251 aminophylline ct, theo von nchembio.273-comp2 theo von ct theophylline von ct, theo | |
| | 48 | | Tazobactam | approved | Phase 4, Phase 3 | 103 | 89786-04-9 | 123630 | (2S,3S,5R)-3-methyl-4,4,7-trioxo-3-(triazol-1-ylmethyl)-4 (2S,3S,5R)-3-methyl-7-oxo-3-(1H-1,2,3-triazol-1-ylmethyl)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 4,4-dioxide 89785-84-2 89786-04-9 AC-7620 AC1L3X07 BIDD:GT0212 C07771 CHEBI:100207 CHEMBL404 | CID123630 CL-298741 CL298741 D00660 DB01606 MolPort-002-500-123 TAZ Tazobactam Tazobactam (JAN/USAN/INN) YTR-830H YTR830H | |
| | 49 | | Abatacept | approved | Phase 4, Phase 2 | 197 | 332348-12-6 | 10237 | | CTLA4-IgG4m CTLA4Ig CTLA4IgG4m |
| | 50 | | Liraglutide | approved | Phase 4, Phase 3 | 329 | 204656-20-2 | | 204656-20-2 Arg34Lys26-(N-ε-(γ-Glu(N-α-hexadecanoyl)))-GLP-1[7-37] C439759 Liraglutida Liraglutida [INN-Spanish] Liraglutide Liraglutide [USAN:INN] Liraglutide recombinant Liraglutidum Liraglutidum [INN-Latin] N26-(Hexadecanoyl-gamma-glutamyle)-(34-arginine)GLP-1-(7-37)-peptide | N26-(Hexadecanoyl-gamma-glutamyle)-(34-arginine)glucagon-like-peptide-1-(7-37)-peptide NN 2211 NN-2211 NN2211 NNC 90-1170 N²⁶-(N-Hexadecanoyl-L-gamma-glutamyl)-[34-L-arginine]glucagon-like peptide 1-(7-37)-peptide N²⁶-(hexadecanoyl-gamma-glutamyle)-[34-arginine]GLP-1-(7-37)-peptide UNII-839I73S42A Victoza nn 2211 nn2211 victoza | |
|
Interventional clinical trials: (show top 50)
(show all 4161)
| id | Name | Status | NCT ID | Phase |
|---|
| 1 | A Study of PAD Versus Velcade, Cyclophosphamide and Dexamethasone (VCD) Treatment in Subjects With Multiple Myeloma | Unknown status | NCT01868828 | Phase 4 | | 2 | Pseudohyponatremia of Multiple Myeloma is True Hyponatremia | Unknown status | NCT01425606 | Phase 4 | | 3 | Efficacy Study of PAD and TAD in Newly Diagnosed Multiple Myeloma | Unknown status | NCT01249690 | Phase 4 | | 4 | Stage I Multiple Myeloma Treatment | Unknown status | NCT00733538 | Phase 4 | | 5 | Additional Effects of Perioperative Immunonutrition in Patients Undergoing Pancreaticoduodenectomy | Unknown status | NCT01969110 | Phase 4 | | 6 | THE USE OF N-ACETYLCYSTEINE ATTENUATING CISPLATIN-INDUCED TOXICITIES BY OXIDATIVE STRESS | Unknown status | NCT02241876 | Phase 4 | | 7 | HIV Persistence and Viral Reservoirs | Unknown status | NCT01025427 | Phase 4 | | 8 | Effect of Perioperative Glucocorticoid Replacement on Prognosis of Surgical Patients With Sellar Lesions | Unknown status | NCT02190994 | Phase 4 | | 9 | Pharmacokinetics/ Pharmacodynamics (PK/PD) Study of Vancomycin | Unknown status | NCT02443064 | Phase 4 | | 10 | Observational Study to Evaluate the Efficacy and Safety of Bortezomib, Melphalan, Prednisone (VMP) in Participants With Multiple Myeloma | Completed | NCT02474563 | Phase 4 | | 11 | A Pharmacokinetic Study of Bortezomib in Taiwanese Participants With Multiple Myeloma | Completed | NCT02268890 | Phase 4 | | 12 | An Observational Study of Chinese Multiple Myeloma Patients Treated With Velcade | Completed | NCT01675245 | Phase 4 | | 13 | Retrospective Survey of Re-treatment With Bortezomib | Completed | NCT01524445 | Phase 4 | | 14 | A Study to Record in an Observational Manner the Treatment of Multiple Myeloma as it is Being Done in Every Day Practice Without Providing Any Investigational Drug or Prescribing Any Procedure | Completed | NCT01241396 | Phase 4 | | 15 | Efficacy of Panobinostat in Patients With Relapsed and Bortezomib-refractory Multiple Myeloma | Completed | NCT01083602 | Phase 4 | | 16 | Quality of Life of Non-transplant Candidate Multiple Myeloma Patients Treated With Early Bortezomib | Completed | NCT01060202 | Phase 4 | | 17 | A Retreatment Study With Bortezomib for Multiple Myeloma | Completed | NCT01030302 | Phase 4 | | 18 | Observational Study of the Effects Intravenous Bortezomib Has on Osteoblast (Cell That is Responsible for Bone Formation) Activity in Multiple Myeloma Patients. | Completed | NCT01026701 | Phase 4 | | 19 | Quality of Life in Multiple Myeloma Patients Treated With Bortezomib | Completed | NCT01021592 | Phase 4 | | 20 | Bortezomib/Adriamycine/Melfalan/Prednisone (VAMP)/Thalidomide/Cyclophosphamide/Dexamethasone (TaCyDex) or Bortezomib/Melfalan/Prednisone (V-MP)/TaCyDex) in Refractary or Relapsed Multiple Myeloma | Completed | NCT00652041 | Phase 4 | | 21 | Zoledronic Acid Treatment (Every 4 or 12 Weeks) to Prevent Skeletal Complications in Advanced Multiple Myeloma Patients | Completed | NCT00622505 | Phase 4 | | 22 | VALEO: A Post Authorization Study, Designed to Learn More About the Safety and Effectiveness of the Use of Bortezomib in the Netherlands | Completed | NCT00440765 | Phase 4 | | 23 | ADVANCE: An Observational Study To Determine Bortezomib Safety and Effectiveness at First Relapse After Participation In First Line HOVON-49/50 Clinical Studies. | Completed | NCT00440479 | Phase 4 | | 24 | Evaluation of VELCADE Given as Retreatment to Multiple Myeloma Patients for Efficacy, Safety and Tolerability | Completed | NCT00257114 | Phase 4 | | 25 | FREE Study - Fracture Reduction Evaluation | Completed | NCT00211211 | Phase 4 | | 26 | A Multiple Myeloma Trial in Patients With Bone Metastases | Completed | NCT00104104 | Phase 4 | | 27 | Observational Study in Participants With Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM) and Non-Hodgkin's Lymphoma (NHL) in Latin America | Completed | NCT02559583 | Phase 4 | | 28 | Clinical And Economic Impact Of Upfront Plerixafor In Autologous Transplantation | Completed | NCT01339572 | Phase 4 | | 29 | Bortezomib (Velcade) - Regulatory Post Marketing Surveillance (PMS) | Completed | NCT01005628 | Phase 4 | | 30 | Long Term Efficacy and Safety of Zoledronic Acid Treatment in Patients With Bone Metastases | Completed | NCT00434447 | Phase 4 | | 31 | PROMPT - Palifermin in Reduction of Oral Mucositis in PBSC Transplantation | Completed | NCT00352703 | Phase 4 | | 32 | Treatment With Zoledronic Acid in Patients With Breast Cancer, Multiple Myeloma, and Prostate Cancer With Cancer Related Bone Lesions | Completed | NCT00029224 | Phase 4 | | 33 | Bone Marrow Transplantation in Treating Patients With Hematologic Cancer | Completed | NCT00003398 | Phase 4 | | 34 | REmoval of Free Light Chains. A COmpaRison of Three Different dialyzERs | Completed | NCT02950389 | Phase 4 | | 35 | Effect of Epoetin Alfa on Hemoglobin, Symptom Distress, and Quality of Life in Patients Receiving Chemotherapy | Completed | NCT00524407 | Phase 4 | | 36 | Study Comparing Piperacillin-tazobactam Versus Piperacillin-tazobactam Plus Glycopeptide in Neutropenic Patients | Completed | NCT00195533 | Phase 4 | | 37 | Busulfan Safety/Efficacy as Conditioning Prior to Hematopoietic Cell Transplantation (HCT) | Completed | NCT00361140 | Phase 4 | | 38 | Registry of Patients Treated With Plerixafor (Mozobil®) for Haematopoietic Stem Cell Mobilization Before Autologous Transplantation | Completed | NCT01738373 | Phase 4 | | 39 | CAFE Study - Cancer Patient Fracture Evaluation | Completed | NCT00211237 | Phase 4 | | 40 | Cytochrom p450 3A4 and 1A2 Phenotyping for the Individualization of Treatment With Sunitinib or Erlotinib in Cancer Patients | Completed | NCT01402089 | Phase 4 | | 41 | Analysis of Data Collected in the European Group for Blood and Marrow Transplantation (EBMT) Registry for Off-Label Transplant Use of Plerixafor | Completed | NCT01362985 | Phase 4 | | 42 | Rapamycin In Angiomyolipomas In Patients With Tuberous Sclerosis | Completed | NCT01217125 | Phase 4 | | 43 | Anti-Inflammatory Actions of Valsartan in Patients With Type 2 Diabetes Mellitus | Completed | NCT00982358 | Phase 4 | | 44 | Sitagliptin Improved Beta Cell Function and Prevented a Conversion Rate to Impaired Glucose Tolerance and Type 2 Diabetes in Metformin Intolerant Obese Women With Polycystic Ovary Syndrome | Completed | NCT03122041 | Phase 4 | | 45 | Phase 3/4 Study of a Recombinant Protein-Free Factor VIII (rAHF-PFM): Comparison of Continuous Infusion Versus Intermittent Bolus Infusion in Hemophilia A Subjects Undergoing Major Orthopedic Surgery | Completed | NCT00357656 | Phase 4 | | 46 | Evaluation of Approved Weight-Based Dose Compared to Fixed Dose of Plerixafor in Patients With Non-Hodgkin's Lymphoma (NHL) Weighing Less Than 70 Kilograms | Completed | NCT01164475 | Phase 4 | | 47 | Anti-Retrovirals for Kaposi's Sarcoma | Completed | NCT00444379 | Phase 4 | | 48 | Efficacy and Safety of Pioglitazone in Treating Subjects With Vascular Complications Associated With Type 2 Diabetes Mellitus. | Completed | NCT00770835 | Phase 4 | | 49 | Effects of Metformin Plus Simvastatin on Polycystic Ovarian Syndrome (PCOS): A Prospective, Randomized, Double-Blind, Placebo-Controlled Study | Completed | NCT01021579 | Phase 4 | | 50 | Study of Azacitidine in Adult Taiwanese Subjects With Higher-Risk Myelodysplastic Syndromes (MDS) | Completed | NCT01201811 | Phase 4 |
Inferred drug relations via UMLS68/NDF-RT46:
Cochrane evidence based reviews: paraproteinemias
|
